data_1lip_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1lip _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.523 ' OD1' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.616 ' N ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -53.99 -31.99 52.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 108.694 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . . . -66.46 -53.8 26.6 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' VAL . 1.9 tt0 -62.35 -62.46 1.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.076 -1.25 . . . . 0.0 108.249 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 51' ' ' LEU . 88.9 t -39.17 -44.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -62.88 -51.37 67.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.998 -1.063 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 m -55.93 -31.12 62.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 110.986 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mmmm -97.33 -14.71 21.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 111.475 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.558 ' CG ' ' O ' ' A' ' 6' ' ' VAL . 4.2 mmt -99.13 -12.77 20.19 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.582 -1.324 . . . . 0.0 109.788 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 20.3 ptmt -77.81 -25.39 0.48 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.671 -0.643 . . . . 0.0 110.71 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 37.2 Cg_endo -83.42 -23.3 3.49 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.739 1.626 . . . . 0.0 108.396 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' HD12 ' A' ' 81' ' ' ILE . 5.3 m -70.79 -5.93 33.93 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.57 0.7 . . . . 0.0 109.232 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 58.8 mt -66.7 -44.38 81.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.571 -0.706 . . . . 0.0 109.859 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -56.52 -25.08 50.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.849 -1.157 . . . . 0.0 109.749 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CD2' HG11 ' A' ' 17' ' ' VAL . 3.9 t80 -89.0 -68.82 0.75 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 109.467 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.525 ' HA ' ' CB ' ' A' ' 65' ' ' ASN . 5.4 m -49.43 -24.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 110.937 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.555 ' CB ' HG22 ' A' ' 58' ' ' ILE . 1.7 pt20 -118.38 -44.36 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.871 -1.143 . . . . 0.0 110.311 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -58.0 -43.37 95.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 120.16 -45.52 1.23 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 36.0 Cg_endo -79.01 133.78 11.32 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.014 1.809 . . . . 0.0 110.65 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.35 -167.21 23.91 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HG2' ' HE3' ' A' ' 72' ' ' LYS . 35.7 Cg_endo -77.14 175.04 49.89 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.145 -1.606 . . . . 0.0 110.472 -0.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.97 13.23 25.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.47 -48.64 3.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 1.2 pp20? -62.88 -18.88 63.57 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.338 -1.096 . . . . 0.0 109.297 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.75 -56.58 7.62 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.065 -1.022 . . . . 0.0 108.88 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 0.8 OUTLIER -65.38 -33.82 76.87 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.37 -0.831 . . . . 0.0 109.067 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -74.27 -21.23 59.85 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.004 -1.06 . . . . 0.0 108.141 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 29' ' ' ASN . . . -74.18 -52.24 7.96 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 13.0 t -60.14 -36.96 71.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 5.9 ttp-105 -64.81 -32.27 73.88 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 12.6 t0 -55.58 -46.08 77.3 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.599 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 1.6 mp -57.88 -43.81 86.28 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.594 ' CE1' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -48.78 -43.7 38.2 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.634 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -79.59 -26.35 41.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.78 -72.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.825 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -63.29 136.8 57.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' O ' ' C ' ' A' ' 45' ' ' GLN . 5.0 mpt_? -65.17 -44.08 89.67 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.943 -1.098 . . . . 0.0 108.59 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 44' ' ' ARG . 41.1 mm-40 -29.65 -60.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.136 0.494 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.616 ' CG2' ' N ' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -53.22 -58.18 7.94 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 98.3 t -58.13 -78.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.565 0.698 . . . . 0.0 110.889 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 46.9 t -40.66 -61.05 1.0 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.506 -0.746 . . . . 0.0 110.068 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 58.7 m-20 -46.38 -42.33 14.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.99 . . . . 0.0 108.965 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -58.59 -69.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 108.599 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 6' ' ' VAL . 8.6 mp -43.32 -26.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.209 -0.932 . . . . 0.0 110.09 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -71.47 -63.78 1.05 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 108.736 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.11 -54.48 25.95 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 7' ' ' ASP . 42.9 mt -53.53 -66.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 109.108 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' CB ' ' N ' ' A' ' 82' ' ' SER . . . -51.23 -20.94 1.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.802 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 1.4 tmm_? -98.69 50.29 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.315 -0.866 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.67 25.53 0.58 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.555 HG22 ' CB ' ' A' ' 18' ' ' GLN . 12.8 mt -114.1 153.9 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.992 -0.711 . . . . 0.0 109.5 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.528 ' N ' HG21 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.14 -62.55 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.907 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.95 72.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' A' ' 83' ' ' PRO . 1.7 tt -48.22 149.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.85 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -109.06 120.0 41.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.812 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 67' ' ' ALA . 0.9 OUTLIER -68.73 -36.64 78.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' ND2' ' C ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -53.44 -56.32 17.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.479 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.525 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . 48.0 m-80 -64.97 -41.07 95.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 69' ' ' ILE . . . -79.57 5.17 13.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.469 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -113.54 2.64 15.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.298 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.5 t -115.81 0.35 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 110.192 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.61 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -55.62 -49.34 93.24 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.989 -1.07 . . . . 0.0 109.493 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 69' ' ' ILE . 35.4 Cg_endo -78.61 -42.09 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.382 2.055 . . . . 0.0 110.273 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -60.03 -21.55 61.52 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.151 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HE3' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -93.43 -54.69 3.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.9 -0.15 20.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.025 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 50.86 45.83 26.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' CE1' ' A' ' 35' ' ' HIS . 0.2 OUTLIER -93.06 -38.65 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.06 -1.025 . . . . 0.0 109.392 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER 75.08 42.33 0.26 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.767 -0.583 . . . . 0.0 110.836 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -79.65 161.84 65.23 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 77' ' ' VAL . 37.4 Cg_endo -89.63 -35.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.743 1.629 . . . . 0.0 109.547 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.3 p90 -98.43 179.11 4.82 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 79' ' ' TYR . 27.2 p -160.86 171.5 18.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -0.975 . . . . 0.0 108.434 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.647 ' O ' ' CG1' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -79.95 83.4 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 123.133 1.444 . . . . 0.0 107.163 178.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 1.2 t -151.71 160.84 31.05 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.198 -0.938 . . . . 0.0 109.406 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HD3' ' CD2' ' A' ' 61' ' ' LEU . 37.2 Cg_endo -85.23 26.19 0.66 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.48 2.12 . . . . 0.0 110.188 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' ILE . 40.2 t0 -148.58 -12.44 0.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.781 -1.199 . . . . 0.0 112.407 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CD1' ' O ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -52.46 -178.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.15 -1.594 . . . . 0.0 109.066 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -136.06 119.74 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.499 ' HA ' ' CG1' ' A' ' 90' ' ' ILE . 19.0 m -93.22 -25.15 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.412 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -13.18 55.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.885 . . . . 0.0 109.554 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.88 46.11 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.522 HD12 ' CB ' ' A' ' 48' ' ' CYS . 47.2 mt -83.79 106.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.171 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.465 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 6' ' ' VAL . 4.6 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.451 0.643 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 1.1 t -82.97 -31.75 27.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.194 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.95 -66.17 2.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -56.03 -62.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.082 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 5' ' ' GLN . 99.2 t -40.66 -31.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.533 -0.73 . . . . 0.0 109.482 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.555 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -73.9 -63.32 1.24 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 108.826 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 8.9 t -49.54 -19.88 0.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -97.34 -29.85 13.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.979 -1.076 . . . . 0.0 110.658 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.592 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 1.5 mmm -98.03 -3.17 38.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.747 -1.221 . . . . 0.0 110.739 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.763 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -86.3 -21.71 0.28 Allowed Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 110.338 177.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 35.1 Cg_endo -79.55 -4.38 13.53 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 107.649 -1.712 . . . . 0.0 107.649 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -86.67 0.56 54.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -57.77 -67.06 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.242 -0.911 . . . . 0.0 109.96 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -39.49 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 110.662 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 8.3 t80 -81.12 -60.75 2.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.667 -1.271 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 18' ' ' GLN . 25.8 m -64.06 -49.68 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.207 -0.933 . . . . 0.0 111.355 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 58' ' ' ILE . 1.1 pt20 -91.12 4.97 50.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.906 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -112.07 -56.17 0.46 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.896 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 125.05 -49.44 0.91 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.8 Cg_endo -78.56 115.83 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.221 1.947 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.72 -165.15 29.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 35.1 Cg_endo -79.13 -177.84 22.04 Favored 'Cis proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.125 -1.614 . . . . 0.0 110.48 0.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -86.16 13.56 7.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.218 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.79 3.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 23' ' ' PRO . 1.3 m -60.45 -55.24 35.89 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 29' ' ' ASN . 1.6 p -65.56 -43.12 90.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -62.29 -20.6 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 33' ' ' ASP . . . -74.76 -56.38 4.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 16.4 t -53.94 -51.29 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.396 . . . . 0.0 108.734 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 10.7 ttt85 -57.79 -30.44 65.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 33.6 t0 -57.87 -46.65 84.55 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.621 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -55.09 -36.69 65.92 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -56.55 -47.17 80.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.965 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.88 -28.7 64.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -81.11 -76.79 0.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.184 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -51.7 139.54 20.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.781 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 73.6 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.906 0.384 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.541 ' CB ' HG23 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.98 -59.03 2.91 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.87 -1.144 . . . . 0.0 109.769 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -30.51 -37.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.672 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -66.99 -58.16 5.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.621 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 94.7 t -57.04 -58.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 109.952 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.685 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 16.9 t -47.02 -49.93 20.25 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.1 m-80 -52.95 -40.56 63.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -63.09 -67.51 0.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.775 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.592 ' CD2' ' CG ' ' A' ' 10' ' ' MET . 1.9 mt -46.57 -24.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.829 -1.169 . . . . 0.0 108.993 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 16.1 tttm -76.04 -44.56 38.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.493 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -63.01 -33.68 87.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.566 ' CD1' ' HB2' ' A' ' 10' ' ' MET . 26.4 mt -73.35 -59.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.443 -1.034 . . . . 0.0 109.382 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 82' ' ' SER . . . -57.06 -24.17 51.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.357 -0.839 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.9 36.81 0.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.839 -1.163 . . . . 0.0 109.66 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.88 30.48 2.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.109 -2.397 . . . . 0.0 107.109 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' HB3' ' A' ' 18' ' ' GLN . 4.3 mm -110.34 156.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.46 0.648 . . . . 0.0 110.152 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -97.72 -26.79 14.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -146.2 46.69 1.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.74 . . . . 0.0 109.059 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 58' ' ' ILE . 2.2 tp -57.0 128.76 38.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -85.49 122.74 30.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.5 mm? -71.56 -33.99 69.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.698 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -53.15 60.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.025 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.473 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 39.0 m-80 -64.18 -39.9 94.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 69' ' ' ILE . . . -77.41 -5.04 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 0.0 109.345 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -114.35 15.52 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 14.1 t -129.31 10.63 5.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.575 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -64.46 -51.74 57.9 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 0.0 109.286 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD3' ' CD1' ' A' ' 69' ' ' ILE . 36.1 Cg_endo -77.71 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.315 2.01 . . . . 0.0 109.758 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.75 -23.96 67.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.118 -0.988 . . . . 0.0 108.982 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 68' ' ' SER . 4.4 tptp -85.59 -53.9 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 110.557 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 1.0 OUTLIER -87.57 4.81 42.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.853 -1.155 . . . . 0.0 110.604 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 2.4 m-80 64.16 66.15 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.218 -0.926 . . . . 0.0 111.132 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 32' ' ' ARG . 2.8 t -118.85 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.72 36.88 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.035 -1.041 . . . . 0.0 110.655 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.514 ' CG2' ' CZ ' ' A' ' 79' ' ' TYR . 1.6 p -79.21 141.78 58.27 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.817 -1.177 . . . . 0.0 108.305 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.492 ' HG2' HG12 ' A' ' 90' ' ' ILE . 36.9 Cg_endo -87.09 -35.03 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.422 2.081 . . . . 0.0 108.352 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.685 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 17.2 p90 -96.72 173.86 7.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 2.8 p -157.31 -171.42 3.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.904 -1.123 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.543 HG23 ' CD1' ' A' ' 69' ' ' ILE . 1.7 tp -82.9 71.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.551 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -157.45 154.64 25.91 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.432 ' HD3' ' CD2' ' A' ' 61' ' ' LEU . 37.1 Cg_endo -83.87 12.43 3.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.755 2.303 . . . . 0.0 110.286 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.64 -7.08 8.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 0.0 110.175 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.642 ' CD1' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -55.78 -172.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -0.984 . . . . 0.0 110.334 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -140.8 113.82 8.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 109.391 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.547 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 5.7 m -87.24 -23.99 24.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.197 -0.939 . . . . 0.0 109.668 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 -23.32 55.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.609 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.95 34.87 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.456 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 87' ' ' CYS . 74.8 mt -90.12 127.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.45 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 13.6 t -99.42 -11.67 20.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.15 -60.48 8.79 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -56.3 -57.91 10.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' CG ' ' A' ' 10' ' ' MET . 46.9 t -48.04 -36.5 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.95 -47.18 63.38 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.008 -1.058 . . . . 0.0 110.497 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.49 -30.46 71.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 0.0 111.404 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -96.27 -17.1 20.98 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.949 -1.094 . . . . 0.0 110.189 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 6' ' ' VAL . 18.0 mmt -97.89 -14.98 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.85 -1.157 . . . . 0.0 109.456 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.709 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.91 -28.47 0.9 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 111.184 178.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 36.1 Cg_endo -79.15 -17.86 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 19.1 m -74.04 -4.28 34.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt -73.35 -36.1 66.08 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.478 -0.764 . . . . 0.0 109.632 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.68 -32.41 71.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.944 -1.098 . . . . 0.0 109.352 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' CD2' ' N ' ' A' ' 17' ' ' VAL . 1.9 t80 -85.26 -66.69 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.146 -0.971 . . . . 0.0 109.056 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . 34.3 m -51.54 -20.42 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.284 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -118.92 -51.4 2.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.553 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . -60.31 -43.04 98.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.624 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 121.22 -44.93 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.998 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.0 Cg_endo -77.46 120.61 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.992 1.795 . . . . 0.0 110.844 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 149.7 -168.45 29.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.3 173.29 58.85 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.238 -1.568 . . . . 0.0 110.483 0.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 m -90.84 11.15 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.613 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.99 -47.84 3.19 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -68.21 -20.44 64.84 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.3 -1.118 . . . . 0.0 109.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 m -63.5 -61.97 1.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.02 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.6 p -68.94 -31.86 71.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.37 -0.832 . . . . 0.0 110.05 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 30' ' ' GLY . 1.3 p-10 -71.72 -21.81 61.72 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.674 -1.266 . . . . 0.0 107.941 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 29' ' ' ASN . . . -79.91 -50.3 5.62 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 42.3 t -59.83 -45.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.247 . . . . 0.0 108.702 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.545 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -58.15 -28.0 64.3 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 9.8 t70 -66.08 -46.89 76.08 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.634 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 1.5 mp -53.05 -28.9 26.88 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -64.47 -60.38 3.21 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -54.3 -22.73 12.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 108.672 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -80.95 -35.17 32.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.609 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -71.12 111.44 6.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.229 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 110.303 -179.417 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.552 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.555 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 -27.79 16.99 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 7.6 mp0 -59.51 -46.99 87.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.04 -1.037 . . . . 0.0 108.689 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.581 ' CG2' ' N ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -65.46 -71.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.634 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 24.6 t -44.74 -61.1 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.716 0.77 . . . . 0.0 110.59 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 43.7 t -48.03 -54.7 12.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.693 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 1.9 m-80 -53.83 -29.74 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.086 -1.009 . . . . 0.0 109.135 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 89.9 m -73.32 -70.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.487 -0.758 . . . . 0.0 109.97 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.529 ' CD2' ' HG3' ' A' ' 10' ' ' MET . 3.3 mt -41.5 -37.18 1.03 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 5.2 tttm -70.59 -45.48 65.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 108.809 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -55.07 -28.78 50.19 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 10' ' ' MET . 19.1 mt -83.92 -70.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -1.099 . . . . 0.0 108.51 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' CB ' ' N ' ' A' ' 82' ' ' SER . . . -36.91 -29.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.789 -0.569 . . . . 0.0 110.553 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -85.45 47.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.554 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.34 26.06 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.522 HG12 ' NE2' ' A' ' 18' ' ' GLN . 28.2 mt -115.1 160.63 14.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 122.027 -0.69 . . . . 0.0 109.514 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.508 ' N ' HG21 ' A' ' 58' ' ' ILE . 14.2 m80 -84.06 -61.63 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.935 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.86 63.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 108.945 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' CD2' HD12 ' A' ' 63' ' ' LEU . 1.4 tt -60.56 129.24 40.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 110.032 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 1.1 t-20 -82.8 121.69 27.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 109.412 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' CB ' ' A' ' 67' ' ' ALA . 3.9 mm? -82.9 4.5 25.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 108.763 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.25 -53.05 4.26 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 39.6 m-80 -67.78 -39.9 84.04 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -75.31 0.47 16.59 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.358 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . -121.04 -2.97 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 109.858 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 4.2 t -112.83 6.0 17.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.588 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -62.25 -50.07 81.47 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.001 -1.062 . . . . 0.0 110.198 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 69' ' ' ILE . 35.6 Cg_endo -76.45 -53.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.301 2.001 . . . . 0.0 110.731 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -27.8 66.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.667 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -80.02 -55.82 4.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.984 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -76.82 -1.73 29.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.371 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 1.4 m-20 69.48 34.44 2.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.842 . . . . 0.0 111.54 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 32' ' ' ARG . 4.7 t -79.96 -129.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.54 -1.35 . . . . 0.0 107.884 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -176.55 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.744 -1.222 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -85.49 145.89 43.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' A' ' 77' ' ' VAL . 36.4 Cg_endo -86.84 -33.78 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.078 1.852 . . . . 0.0 108.331 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.6 ' HA ' ' HB ' ' A' ' 85' ' ' ILE . 8.9 p90 -99.44 163.86 12.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.111 0.957 . . . . 0.0 110.776 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' SER . 64.6 p -161.33 165.6 28.82 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.553 ' O ' ' CG1' ' A' ' 81' ' ' ILE . 1.4 pp -54.77 94.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 117.587 -1.645 . . . . 0.0 107.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' THR . 29.3 t -172.5 142.78 1.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.045 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 37.0 Cg_endo -81.4 8.34 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.723 2.282 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.74 -16.35 14.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.348 -0.845 . . . . 0.0 110.208 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -71.49 170.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.908 -1.12 . . . . 0.0 109.933 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -117.31 119.01 33.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 90' ' ' ILE . 81.7 m -95.67 -17.25 21.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.17 -0.956 . . . . 0.0 109.821 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.98 -4.98 38.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.081 -1.012 . . . . 0.0 109.413 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 34.42 5.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 5.0 mt -86.18 115.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.103 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.489 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 1.7 t -75.97 -25.25 55.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.51 -66.94 2.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -58.01 9.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -1.191 . . . . 0.0 109.034 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 10' ' ' MET . 93.9 t -44.81 -27.77 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -76.4 -53.56 7.97 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -58.21 -27.53 63.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -0.823 . . . . 0.0 111.418 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 26.0 mttm -97.51 -28.31 14.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 110.804 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.566 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.66 -2.26 38.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.659 -1.276 . . . . 0.0 110.665 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.776 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -84.07 -21.5 0.29 Allowed Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.24 176.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 34.9 Cg_endo -79.84 -12.88 13.29 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.57 -2.2 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 11' ' ' LYS . 26.4 mt -73.37 -58.61 3.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.488 -0.758 . . . . 0.0 109.799 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.511 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -51.82 -18.0 1.14 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.921 -1.112 . . . . 0.0 110.277 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 17' ' ' VAL . 2.2 t80 -90.45 -63.3 1.29 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.875 -1.141 . . . . 0.0 109.814 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.525 ' N ' ' CD2' ' A' ' 16' ' ' TYR . 35.9 m -54.86 -30.59 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 111.273 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 61' ' ' LEU . 3.7 pt20 -112.92 -20.15 11.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.751 -1.218 . . . . 0.0 110.627 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -86.64 -46.99 5.0 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.099 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 130.99 -49.74 0.92 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.4 Cg_endo -78.38 144.79 20.69 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.292 1.995 . . . . 0.0 110.957 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.81 -165.27 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 176.14 45.23 Favored 'Cis proline' 0 C--N 1.308 -1.556 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.305 0.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -86.92 155.51 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.301 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.67 83.78 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.495 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -57.59 -40.6 79.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.37 -1.077 . . . . 0.0 109.391 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -48.46 -41.31 29.16 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.918 -1.114 . . . . 0.0 108.822 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 m -77.93 -36.53 49.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 109.778 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 4.9 p-10 -73.62 -7.27 51.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.982 -1.074 . . . . 0.0 108.79 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.516 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -98.87 -54.94 1.09 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.501 ' HA ' HD23 ' A' ' 34' ' ' LEU . 13.9 t -59.94 -37.72 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.095 -1.238 . . . . 0.0 107.755 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.4 ttm-85 -61.94 -32.64 73.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 10.6 t70 -61.0 -47.06 88.19 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.639 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 2.1 mp -55.03 -34.15 63.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.91 -73.89 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.297 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -53.89 -21.86 8.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.348 -0.845 . . . . 0.0 110.879 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 17.6 mm100 -79.56 -35.2 40.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.901 -1.125 . . . . 0.0 109.243 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -63.25 131.09 47.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.795 -179.477 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.595 ' CG ' ' CE2' ' A' ' 79' ' ' TYR . 1.7 mpt_? -88.27 -59.57 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.576 ' C ' ' O ' ' A' ' 44' ' ' ARG . 3.3 mp0 -23.08 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.14 0.495 . . . . 0.0 110.299 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -61.73 -57.88 10.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 108.721 178.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.639 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 63.4 t -63.26 -72.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.532 0.682 . . . . 0.0 110.323 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.611 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -39.39 -55.11 1.81 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 93.7 m-20 -50.87 -46.56 60.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.405 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 33.7 m -54.74 -65.06 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.922 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' CD2' ' HG2' ' A' ' 10' ' ' MET . 3.2 mt -44.83 -30.14 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.424 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 55.3 tttt -69.34 -52.08 30.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.99 -43.54 82.83 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.45 HG21 HD22 ' A' ' 14' ' ' LEU . 51.8 mt -61.97 -63.68 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 0.0 108.777 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.532 ' CB ' ' N ' ' A' ' 82' ' ' SER . . . -50.19 -22.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.472 ' HG2' ' HB3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -91.73 49.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.099 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.65 23.49 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 58' ' ' ILE . 14.7 mt -116.75 152.38 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -92.87 -23.05 18.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 109.741 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.71 70.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -80.68 146.01 31.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.475 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 1.6 t-20 -108.72 121.36 44.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.108 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 5.0 mt -81.35 1.61 31.97 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.7 -55.95 3.44 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 16.0 m-80 -68.89 -32.66 72.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' HD12 ' A' ' 69' ' ' ILE . . . -80.21 8.43 7.35 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.689 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 63' ' ' LEU . . . -113.32 -12.98 12.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.084 -1.01 . . . . 0.0 109.065 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -114.22 13.67 17.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 109.762 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.606 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -55.05 -47.47 98.42 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.075 -1.016 . . . . 0.0 109.9 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 69' ' ' ILE . 36.6 Cg_endo -78.84 -64.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.18 1.92 . . . . 0.0 110.458 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' PRO . 1.4 t -44.46 -26.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' SER . 3.4 tppt? -93.22 -35.76 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.53 ' CB ' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -82.45 2.75 31.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.73 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.82 35.29 18.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.416 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -101.76 -31.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 109.084 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 68.33 26.69 6.74 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.725 -0.61 . . . . 0.0 110.081 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.542 ' CG2' ' CE2' ' A' ' 79' ' ' TYR . 1.1 p -79.56 147.77 68.33 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.582 ' HG2' ' CG1' ' A' ' 90' ' ' ILE . 37.4 Cg_endo -86.95 -38.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.296 1.997 . . . . 0.0 108.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.611 ' CG ' ' HB2' ' A' ' 48' ' ' CYS . 15.6 p90 -94.14 152.09 19.0 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.832 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -160.75 163.54 32.22 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -51.62 92.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.806 -1.184 . . . . 0.0 108.737 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.562 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 2.4 t -159.33 156.2 25.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 120.891 -1.131 . . . . 0.0 109.693 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.491 ' HD3' HD23 ' A' ' 61' ' ' LEU . 38.5 Cg_endo -87.7 23.34 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.014 2.476 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 13.5 t70 -149.71 5.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 111.423 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -69.76 -177.86 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.664 -1.272 . . . . 0.0 110.265 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 89' ' ' ARG . 38.0 t0 -145.8 125.9 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.542 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 1.9 m -89.78 -3.98 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.7 15.86 22.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.277 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 18.5 mmt180 -116.94 4.93 12.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.031 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.582 ' CG1' ' HG2' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -102.51 133.32 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.29 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.483 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.574 HD13 ' CB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.768 0.794 . . . . 0.0 109.776 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.541 ' ND2' HD11 ' A' ' 1' ' ' LEU . 0.0 OUTLIER -127.13 -18.79 4.49 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.744 -0.597 . . . . 0.0 110.183 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.616 ' N ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -53.99 -31.99 52.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 108.694 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . . . -66.46 -53.8 26.6 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' VAL . 1.9 tt0 -62.35 -62.46 1.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.076 -1.25 . . . . 0.0 108.249 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 51' ' ' LEU . 88.9 t -39.17 -44.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -62.88 -51.37 67.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.998 -1.063 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 m -55.93 -31.12 62.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 110.986 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mmmm -97.33 -14.71 21.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 111.475 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.558 ' CG ' ' O ' ' A' ' 6' ' ' VAL . 4.2 mmt -99.13 -12.77 20.19 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.582 -1.324 . . . . 0.0 109.788 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 20.3 ptmt -77.81 -25.39 0.48 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.671 -0.643 . . . . 0.0 110.71 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 37.2 Cg_endo -83.42 -23.3 3.49 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.739 1.626 . . . . 0.0 108.396 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' HD12 ' A' ' 81' ' ' ILE . 5.3 m -70.79 -5.93 33.93 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.57 0.7 . . . . 0.0 109.232 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 58.8 mt -66.7 -44.38 81.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.571 -0.706 . . . . 0.0 109.859 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -56.52 -25.08 50.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.849 -1.157 . . . . 0.0 109.749 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CD2' HG11 ' A' ' 17' ' ' VAL . 3.9 t80 -89.0 -68.82 0.75 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 109.467 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.525 ' HA ' ' CB ' ' A' ' 65' ' ' ASN . 5.4 m -49.43 -24.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 110.937 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.555 ' CB ' HG22 ' A' ' 58' ' ' ILE . 1.7 pt20 -118.38 -44.36 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.871 -1.143 . . . . 0.0 110.311 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -58.0 -43.37 95.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 120.16 -45.52 1.23 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 36.0 Cg_endo -79.01 133.78 11.32 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.014 1.809 . . . . 0.0 110.65 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.35 -167.21 23.91 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HG2' ' HE3' ' A' ' 72' ' ' LYS . 35.7 Cg_endo -77.14 175.04 49.89 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.145 -1.606 . . . . 0.0 110.472 -0.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.97 13.23 25.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.47 -48.64 3.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 1.2 pp20? -62.88 -18.88 63.57 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.338 -1.096 . . . . 0.0 109.297 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.75 -56.58 7.62 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.065 -1.022 . . . . 0.0 108.88 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 0.8 OUTLIER -65.38 -33.82 76.87 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.37 -0.831 . . . . 0.0 109.067 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -74.27 -21.23 59.85 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.004 -1.06 . . . . 0.0 108.141 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' OD1' ' A' ' 29' ' ' ASN . . . -74.18 -52.24 7.96 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 13.0 t -60.14 -36.96 71.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' A' ' 35' ' ' HIS . 5.9 ttp-105 -64.81 -32.27 73.88 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 12.6 t0 -55.58 -46.08 77.3 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.599 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 1.6 mp -57.88 -43.81 86.28 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.594 ' CE1' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -48.78 -43.7 38.2 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.634 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -79.59 -26.35 41.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.78 -72.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.825 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -63.29 136.8 57.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -118.07 -37.96 3.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.421 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -114.64 176.17 5.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.033 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -60.41 -50.49 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.143 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.0 -19.42 5.34 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -87.04 -35.85 18.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -1.17 . . . . 0.0 109.493 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' O ' ' C ' ' A' ' 45' ' ' GLN . 5.0 mpt_? -65.17 -44.08 89.67 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.943 -1.098 . . . . 0.0 108.59 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 44' ' ' ARG . 41.1 mm-40 -29.65 -60.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.136 0.494 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.616 ' CG2' ' N ' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -53.22 -58.18 7.94 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 98.3 t -58.13 -78.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.565 0.698 . . . . 0.0 110.889 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 46.9 t -40.66 -61.05 1.0 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.506 -0.746 . . . . 0.0 110.068 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 58.7 m-20 -46.38 -42.33 14.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.99 . . . . 0.0 108.965 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -58.59 -69.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 108.599 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 6' ' ' VAL . 8.6 mp -43.32 -26.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.209 -0.932 . . . . 0.0 110.09 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -71.47 -63.78 1.05 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 108.736 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.11 -54.48 25.95 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 7' ' ' ASP . 42.9 mt -53.53 -66.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 109.108 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' CB ' ' N ' ' A' ' 82' ' ' SER . . . -51.23 -20.94 1.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.802 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 1.4 tmm_? -98.69 50.29 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.315 -0.866 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.67 25.53 0.58 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.555 HG22 ' CB ' ' A' ' 18' ' ' GLN . 12.8 mt -114.1 153.9 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.992 -0.711 . . . . 0.0 109.5 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.528 ' N ' HG21 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.14 -62.55 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.907 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.95 72.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' A' ' 83' ' ' PRO . 1.7 tt -48.22 149.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.85 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -109.06 120.0 41.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.812 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 67' ' ' ALA . 0.9 OUTLIER -68.73 -36.64 78.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' ND2' ' C ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -53.44 -56.32 17.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.479 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.525 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . 48.0 m-80 -64.97 -41.07 95.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.526 ' O ' ' CD1' ' A' ' 69' ' ' ILE . . . -79.57 5.17 13.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.469 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -113.54 2.64 15.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.298 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.5 t -115.81 0.35 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 110.192 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.61 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -55.62 -49.34 93.24 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.989 -1.07 . . . . 0.0 109.493 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 69' ' ' ILE . 35.4 Cg_endo -78.61 -42.09 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.382 2.055 . . . . 0.0 110.273 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -60.03 -21.55 61.52 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.151 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HE3' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -93.43 -54.69 3.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.9 -0.15 20.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.025 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 50.86 45.83 26.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.594 ' HB ' ' CE1' ' A' ' 35' ' ' HIS . 0.2 OUTLIER -93.06 -38.65 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.06 -1.025 . . . . 0.0 109.392 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER 75.08 42.33 0.26 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.767 -0.583 . . . . 0.0 110.836 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -79.65 161.84 65.23 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 77' ' ' VAL . 37.4 Cg_endo -89.63 -35.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.743 1.629 . . . . 0.0 109.547 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.3 p90 -98.43 179.11 4.82 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 79' ' ' TYR . 27.2 p -160.86 171.5 18.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -0.975 . . . . 0.0 108.434 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.647 ' O ' ' CG1' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -79.95 83.4 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 123.133 1.444 . . . . 0.0 107.163 178.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 1.2 t -151.71 160.84 31.05 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.198 -0.938 . . . . 0.0 109.406 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HD3' ' CD2' ' A' ' 61' ' ' LEU . 37.2 Cg_endo -85.23 26.19 0.66 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.48 2.12 . . . . 0.0 110.188 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' ILE . 40.2 t0 -148.58 -12.44 0.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.781 -1.199 . . . . 0.0 112.407 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.589 ' CD1' ' O ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -52.46 -178.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.15 -1.594 . . . . 0.0 109.066 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -136.06 119.74 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.499 ' HA ' ' CG1' ' A' ' 90' ' ' ILE . 19.0 m -93.22 -25.15 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.412 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -13.18 55.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.885 . . . . 0.0 109.554 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.88 46.11 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.522 HD12 ' CB ' ' A' ' 48' ' ' CYS . 47.2 mt -83.79 106.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.171 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.465 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.204 0.526 . . . . 0.0 109.608 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 6' ' ' VAL . 4.6 p30 -158.13 -173.55 4.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.867 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 1.1 t -82.97 -31.75 27.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.194 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.95 -66.17 2.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -56.03 -62.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.082 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 5' ' ' GLN . 99.2 t -40.66 -31.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.533 -0.73 . . . . 0.0 109.482 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.555 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -73.9 -63.32 1.24 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 108.826 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 8.9 t -49.54 -19.88 0.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -97.34 -29.85 13.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.979 -1.076 . . . . 0.0 110.658 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.592 ' CG ' ' CD2' ' A' ' 51' ' ' LEU . 1.5 mmm -98.03 -3.17 38.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.747 -1.221 . . . . 0.0 110.739 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.763 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -86.3 -21.71 0.28 Allowed Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 110.338 177.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 35.1 Cg_endo -79.55 -4.38 13.53 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 107.649 -1.712 . . . . 0.0 107.649 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -86.67 0.56 54.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -57.77 -67.06 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.242 -0.911 . . . . 0.0 109.96 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -39.49 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 110.662 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 8.3 t80 -81.12 -60.75 2.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.667 -1.271 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 18' ' ' GLN . 25.8 m -64.06 -49.68 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.207 -0.933 . . . . 0.0 111.355 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 58' ' ' ILE . 1.1 pt20 -91.12 4.97 50.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.906 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -112.07 -56.17 0.46 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.896 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 125.05 -49.44 0.91 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.8 Cg_endo -78.56 115.83 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.221 1.947 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.72 -165.15 29.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 35.1 Cg_endo -79.13 -177.84 22.04 Favored 'Cis proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.125 -1.614 . . . . 0.0 110.48 0.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -86.16 13.56 7.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.218 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.79 3.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 23' ' ' PRO . 1.3 m -60.45 -55.24 35.89 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 29' ' ' ASN . 1.6 p -65.56 -43.12 90.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -62.29 -20.6 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 33' ' ' ASP . . . -74.76 -56.38 4.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 16.4 t -53.94 -51.29 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.396 . . . . 0.0 108.734 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 35' ' ' HIS . 10.7 ttt85 -57.79 -30.44 65.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 33.6 t0 -57.87 -46.65 84.55 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.621 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -55.09 -36.69 65.92 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -56.55 -47.17 80.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.965 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.88 -28.7 64.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -81.11 -76.79 0.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.184 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -51.7 139.54 20.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -65.66 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.781 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 2.8 m -101.26 -164.36 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.514 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -72.91 -24.17 60.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.67 1.1 39.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 73.6 m-20 -121.55 -29.09 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.24 . . . . 0.0 110.041 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.541 ' CB ' HG23 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.98 -59.03 2.91 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.87 -1.144 . . . . 0.0 109.769 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 41' ' ' SER . 0.7 OUTLIER -30.51 -37.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.672 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -66.99 -58.16 5.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.621 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 94.7 t -57.04 -58.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 109.952 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.685 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 16.9 t -47.02 -49.93 20.25 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.1 m-80 -52.95 -40.56 63.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -63.09 -67.51 0.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.775 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.592 ' CD2' ' CG ' ' A' ' 10' ' ' MET . 1.9 mt -46.57 -24.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.829 -1.169 . . . . 0.0 108.993 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 16.1 tttm -76.04 -44.56 38.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.493 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -63.01 -33.68 87.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.566 ' CD1' ' HB2' ' A' ' 10' ' ' MET . 26.4 mt -73.35 -59.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.443 -1.034 . . . . 0.0 109.382 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 82' ' ' SER . . . -57.06 -24.17 51.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.357 -0.839 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.9 36.81 0.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.839 -1.163 . . . . 0.0 109.66 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.88 30.48 2.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.109 -2.397 . . . . 0.0 107.109 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' HB3' ' A' ' 18' ' ' GLN . 4.3 mm -110.34 156.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.46 0.648 . . . . 0.0 110.152 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -97.72 -26.79 14.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -146.2 46.69 1.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.74 . . . . 0.0 109.059 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 58' ' ' ILE . 2.2 tp -57.0 128.76 38.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -85.49 122.74 30.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 63' ' ' LEU . 3.5 mm? -71.56 -33.99 69.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.698 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -53.15 60.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.025 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.473 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 39.0 m-80 -64.18 -39.9 94.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 69' ' ' ILE . . . -77.41 -5.04 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 0.0 109.345 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -114.35 15.52 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 14.1 t -129.31 10.63 5.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.575 ' CD1' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -64.46 -51.74 57.9 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 0.0 109.286 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD3' ' CD1' ' A' ' 69' ' ' ILE . 36.1 Cg_endo -77.71 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.315 2.01 . . . . 0.0 109.758 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.75 -23.96 67.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.118 -0.988 . . . . 0.0 108.982 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 68' ' ' SER . 4.4 tptp -85.59 -53.9 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 110.557 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 1.0 OUTLIER -87.57 4.81 42.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.853 -1.155 . . . . 0.0 110.604 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 2.4 m-80 64.16 66.15 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.218 -0.926 . . . . 0.0 111.132 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 32' ' ' ARG . 2.8 t -118.85 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.72 36.88 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.035 -1.041 . . . . 0.0 110.655 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.514 ' CG2' ' CZ ' ' A' ' 79' ' ' TYR . 1.6 p -79.21 141.78 58.27 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.817 -1.177 . . . . 0.0 108.305 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.492 ' HG2' HG12 ' A' ' 90' ' ' ILE . 36.9 Cg_endo -87.09 -35.03 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.422 2.081 . . . . 0.0 108.352 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.685 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 17.2 p90 -96.72 173.86 7.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.508 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 2.8 p -157.31 -171.42 3.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.904 -1.123 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.543 HG23 ' CD1' ' A' ' 69' ' ' ILE . 1.7 tp -82.9 71.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.551 ' O ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -157.45 154.64 25.91 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.432 ' HD3' ' CD2' ' A' ' 61' ' ' LEU . 37.1 Cg_endo -83.87 12.43 3.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.755 2.303 . . . . 0.0 110.286 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.64 -7.08 8.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 0.0 110.175 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.642 ' CD1' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -55.78 -172.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -0.984 . . . . 0.0 110.334 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -140.8 113.82 8.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 109.391 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.547 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 5.7 m -87.24 -23.99 24.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.197 -0.939 . . . . 0.0 109.668 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 -23.32 55.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.609 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.95 34.87 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.456 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 87' ' ' CYS . 74.8 mt -90.12 127.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.45 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 37' ' ' GLN . 4.0 pp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.429 ' N ' ' CD1' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -141.15 -165.76 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 13.6 t -99.42 -11.67 20.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.15 -60.48 8.79 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -56.3 -57.91 10.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' CG ' ' A' ' 10' ' ' MET . 46.9 t -48.04 -36.5 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.95 -47.18 63.38 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.008 -1.058 . . . . 0.0 110.497 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.49 -30.46 71.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 0.0 111.404 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -96.27 -17.1 20.98 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.949 -1.094 . . . . 0.0 110.189 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 6' ' ' VAL . 18.0 mmt -97.89 -14.98 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.85 -1.157 . . . . 0.0 109.456 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.709 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.91 -28.47 0.9 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 111.184 178.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.709 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 36.1 Cg_endo -79.15 -17.86 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 19.1 m -74.04 -4.28 34.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.506 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt -73.35 -36.1 66.08 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.478 -0.764 . . . . 0.0 109.632 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.68 -32.41 71.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.944 -1.098 . . . . 0.0 109.352 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' CD2' ' N ' ' A' ' 17' ' ' VAL . 1.9 t80 -85.26 -66.69 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.146 -0.971 . . . . 0.0 109.056 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . 34.3 m -51.54 -20.42 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.284 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -118.92 -51.4 2.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.553 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . -60.31 -43.04 98.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.624 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 121.22 -44.93 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.998 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.0 Cg_endo -77.46 120.61 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.992 1.795 . . . . 0.0 110.844 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 149.7 -168.45 29.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.3 173.29 58.85 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.238 -1.568 . . . . 0.0 110.483 0.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 m -90.84 11.15 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.613 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.99 -47.84 3.19 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -68.21 -20.44 64.84 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.3 -1.118 . . . . 0.0 109.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 m -63.5 -61.97 1.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.02 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.6 p -68.94 -31.86 71.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.37 -0.832 . . . . 0.0 110.05 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 30' ' ' GLY . 1.3 p-10 -71.72 -21.81 61.72 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.674 -1.266 . . . . 0.0 107.941 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 29' ' ' ASN . . . -79.91 -50.3 5.62 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 42.3 t -59.83 -45.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.247 . . . . 0.0 108.702 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.545 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -58.15 -28.0 64.3 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 9.8 t70 -66.08 -46.89 76.08 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.634 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 1.5 mp -53.05 -28.9 26.88 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -64.47 -60.38 3.21 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -54.3 -22.73 12.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 108.672 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.52 ' HB3' ' CD2' ' A' ' 1' ' ' LEU . 14.0 mm-40 -80.95 -35.17 32.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.609 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -71.12 111.44 6.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.229 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -151.33 -35.37 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 110.303 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' SER . 45.2 p -78.7 -129.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 108.242 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -43.63 -28.16 0.37 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.784 -1.197 . . . . 0.0 108.058 178.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 149.4 -27.12 1.22 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.552 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 56.91 18.52 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.555 ' HB3' ' CD1' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 -27.79 16.99 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 7.6 mp0 -59.51 -46.99 87.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.04 -1.037 . . . . 0.0 108.689 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.581 ' CG2' ' N ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -65.46 -71.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.634 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 24.6 t -44.74 -61.1 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.716 0.77 . . . . 0.0 110.59 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 43.7 t -48.03 -54.7 12.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.693 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 1.9 m-80 -53.83 -29.74 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.086 -1.009 . . . . 0.0 109.135 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 89.9 m -73.32 -70.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.487 -0.758 . . . . 0.0 109.97 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.529 ' CD2' ' HG3' ' A' ' 10' ' ' MET . 3.3 mt -41.5 -37.18 1.03 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 5.2 tttm -70.59 -45.48 65.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 108.809 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -55.07 -28.78 50.19 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 10' ' ' MET . 19.1 mt -83.92 -70.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -1.099 . . . . 0.0 108.51 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' CB ' ' N ' ' A' ' 82' ' ' SER . . . -36.91 -29.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.789 -0.569 . . . . 0.0 110.553 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -85.45 47.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.554 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.34 26.06 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.522 HG12 ' NE2' ' A' ' 18' ' ' GLN . 28.2 mt -115.1 160.63 14.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 122.027 -0.69 . . . . 0.0 109.514 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.508 ' N ' HG21 ' A' ' 58' ' ' ILE . 14.2 m80 -84.06 -61.63 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.935 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.86 63.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 108.945 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' CD2' HD12 ' A' ' 63' ' ' LEU . 1.4 tt -60.56 129.24 40.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 110.032 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 1.1 t-20 -82.8 121.69 27.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 109.412 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' CB ' ' A' ' 67' ' ' ALA . 3.9 mm? -82.9 4.5 25.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 108.763 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.25 -53.05 4.26 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 39.6 m-80 -67.78 -39.9 84.04 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -75.31 0.47 16.59 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.358 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . -121.04 -2.97 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 109.858 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 4.2 t -112.83 6.0 17.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.588 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -62.25 -50.07 81.47 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.001 -1.062 . . . . 0.0 110.198 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 69' ' ' ILE . 35.6 Cg_endo -76.45 -53.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.301 2.001 . . . . 0.0 110.731 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -27.8 66.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.667 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -80.02 -55.82 4.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.984 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -76.82 -1.73 29.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.371 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 1.4 m-20 69.48 34.44 2.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.842 . . . . 0.0 111.54 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.492 HG12 ' HB2' ' A' ' 32' ' ' ARG . 4.7 t -79.96 -129.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.54 -1.35 . . . . 0.0 107.884 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -176.55 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.744 -1.222 . . . . 0.0 109.837 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.508 ' CG2' ' CZ ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -85.49 145.89 43.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' A' ' 77' ' ' VAL . 36.4 Cg_endo -86.84 -33.78 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.078 1.852 . . . . 0.0 108.331 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.6 ' HA ' ' HB ' ' A' ' 85' ' ' ILE . 8.9 p90 -99.44 163.86 12.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.111 0.957 . . . . 0.0 110.776 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 82' ' ' SER . 64.6 p -161.33 165.6 28.82 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.553 ' O ' ' CG1' ' A' ' 81' ' ' ILE . 1.4 pp -54.77 94.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 117.587 -1.645 . . . . 0.0 107.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 80' ' ' THR . 29.3 t -172.5 142.78 1.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.045 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 55' ' ' ALA . 37.0 Cg_endo -81.4 8.34 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.723 2.282 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.74 -16.35 14.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.348 -0.845 . . . . 0.0 110.208 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -71.49 170.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.908 -1.12 . . . . 0.0 109.933 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -117.31 119.01 33.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.503 ' HA ' HD13 ' A' ' 90' ' ' ILE . 81.7 m -95.67 -17.25 21.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.17 -0.956 . . . . 0.0 109.821 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.98 -4.98 38.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.081 -1.012 . . . . 0.0 109.413 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 34.42 5.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 5.0 mt -86.18 115.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.103 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.489 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.381 0.61 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -145.98 -166.58 2.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.098 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 1.7 t -75.97 -25.25 55.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.51 -66.94 2.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -58.01 9.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -1.191 . . . . 0.0 109.034 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 10' ' ' MET . 93.9 t -44.81 -27.77 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -76.4 -53.56 7.97 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -58.21 -27.53 63.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -0.823 . . . . 0.0 111.418 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 26.0 mttm -97.51 -28.31 14.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 110.804 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.566 ' HG2' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.66 -2.26 38.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.659 -1.276 . . . . 0.0 110.665 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.776 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -84.07 -21.5 0.29 Allowed Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.24 176.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.776 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 34.9 Cg_endo -79.84 -12.88 13.29 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.2 m -80.57 -2.2 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 11' ' ' LYS . 26.4 mt -73.37 -58.61 3.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.488 -0.758 . . . . 0.0 109.799 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.511 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -51.82 -18.0 1.14 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.921 -1.112 . . . . 0.0 110.277 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.525 ' CD2' ' N ' ' A' ' 17' ' ' VAL . 2.2 t80 -90.45 -63.3 1.29 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.875 -1.141 . . . . 0.0 109.814 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.525 ' N ' ' CD2' ' A' ' 16' ' ' TYR . 35.9 m -54.86 -30.59 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 111.273 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 61' ' ' LEU . 3.7 pt20 -112.92 -20.15 11.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.751 -1.218 . . . . 0.0 110.627 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -86.64 -46.99 5.0 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.099 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 130.99 -49.74 0.92 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.4 Cg_endo -78.38 144.79 20.69 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.292 1.995 . . . . 0.0 110.957 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.81 -165.27 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 176.14 45.23 Favored 'Cis proline' 0 C--N 1.308 -1.556 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.305 0.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -86.92 155.51 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.301 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.67 83.78 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -57.59 -40.6 79.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.37 -1.077 . . . . 0.0 109.391 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -48.46 -41.31 29.16 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.918 -1.114 . . . . 0.0 108.822 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 m -77.93 -36.53 49.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 109.778 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 4.9 p-10 -73.62 -7.27 51.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.982 -1.074 . . . . 0.0 108.79 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -98.87 -54.94 1.09 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.501 ' HA ' HD23 ' A' ' 34' ' ' LEU . 13.9 t -59.94 -37.72 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.095 -1.238 . . . . 0.0 107.755 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.4 ttm-85 -61.94 -32.64 73.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 10.6 t70 -61.0 -47.06 88.19 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.639 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 2.1 mp -55.03 -34.15 63.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.91 -73.89 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.297 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -53.89 -21.86 8.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.348 -0.845 . . . . 0.0 110.879 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 17.6 mm100 -79.56 -35.2 40.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.901 -1.125 . . . . 0.0 109.243 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 42' ' ' GLY . . . -63.25 131.09 47.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -151.62 -39.01 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.795 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.4 m -79.02 -131.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.847 -1.158 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -45.3 -26.95 0.58 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 152.49 -20.53 0.82 Allowed Glycine 0 C--O 1.208 -1.529 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 58.06 20.52 6.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.595 ' CG ' ' CE2' ' A' ' 79' ' ' TYR . 1.7 mpt_? -88.27 -59.57 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.576 ' C ' ' O ' ' A' ' 44' ' ' ARG . 3.3 mp0 -23.08 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.14 0.495 . . . . 0.0 110.299 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -61.73 -57.88 10.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 108.721 178.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.639 ' CG1' ' CD2' ' A' ' 34' ' ' LEU . 63.4 t -63.26 -72.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.532 0.682 . . . . 0.0 110.323 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.611 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -39.39 -55.11 1.81 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 93.7 m-20 -50.87 -46.56 60.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.405 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 33.7 m -54.74 -65.06 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.922 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' CD2' ' HG2' ' A' ' 10' ' ' MET . 3.2 mt -44.83 -30.14 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.424 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 55.3 tttt -69.34 -52.08 30.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.99 -43.54 82.83 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.45 HG21 HD22 ' A' ' 14' ' ' LEU . 51.8 mt -61.97 -63.68 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 0.0 108.777 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.532 ' CB ' ' N ' ' A' ' 82' ' ' SER . . . -50.19 -22.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.472 ' HG2' ' HB3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -91.73 49.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.099 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.65 23.49 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 58' ' ' ILE . 14.7 mt -116.75 152.38 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -92.87 -23.05 18.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 109.741 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.71 70.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 18' ' ' GLN . 0.9 OUTLIER -80.68 146.01 31.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.475 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 1.6 t-20 -108.72 121.36 44.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.108 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 5.0 mt -81.35 1.61 31.97 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.7 -55.95 3.44 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 16.0 m-80 -68.89 -32.66 72.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.49 ' O ' HD12 ' A' ' 69' ' ' ILE . . . -80.21 8.43 7.35 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.689 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 63' ' ' LEU . . . -113.32 -12.98 12.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.084 -1.01 . . . . 0.0 109.065 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -114.22 13.67 17.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 109.762 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.606 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -55.05 -47.47 98.42 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.075 -1.016 . . . . 0.0 109.9 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 69' ' ' ILE . 36.6 Cg_endo -78.84 -64.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.18 1.92 . . . . 0.0 110.458 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' PRO . 1.4 t -44.46 -26.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' SER . 3.4 tppt? -93.22 -35.76 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.53 ' CB ' ' CG2' ' A' ' 75' ' ' VAL . 18.0 m -82.45 2.75 31.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.73 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.82 35.29 18.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.416 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -101.76 -31.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 109.084 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 68.33 26.69 6.74 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.725 -0.61 . . . . 0.0 110.081 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.542 ' CG2' ' CE2' ' A' ' 79' ' ' TYR . 1.1 p -79.56 147.77 68.33 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.582 ' HG2' ' CG1' ' A' ' 90' ' ' ILE . 37.4 Cg_endo -86.95 -38.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.296 1.997 . . . . 0.0 108.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.611 ' CG ' ' HB2' ' A' ' 48' ' ' CYS . 15.6 p90 -94.14 152.09 19.0 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.832 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -160.75 163.54 32.22 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -51.62 92.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.806 -1.184 . . . . 0.0 108.737 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.562 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 2.4 t -159.33 156.2 25.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 120.891 -1.131 . . . . 0.0 109.693 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.491 ' HD3' HD23 ' A' ' 61' ' ' LEU . 38.5 Cg_endo -87.7 23.34 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.014 2.476 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 13.5 t70 -149.71 5.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 111.423 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -69.76 -177.86 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.664 -1.272 . . . . 0.0 110.265 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 89' ' ' ARG . 38.0 t0 -145.8 125.9 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.542 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 1.9 m -89.78 -3.98 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.7 15.86 22.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.277 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 18.5 mmt180 -116.94 4.93 12.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.031 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.582 ' CG1' ' HG2' ' A' ' 78' ' ' PRO . 0.5 OUTLIER -102.51 133.32 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.29 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.483 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.66 ' CG ' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.813 ' N ' HG23 ' A' ' 46' ' ' THR . 0.5 OUTLIER -53.99 -31.99 52.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 108.694 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . . . -66.46 -53.8 26.6 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' VAL . 1.9 tt0 -62.35 -62.46 1.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.076 -1.25 . . . . 0.0 108.249 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 47' ' ' VAL . 88.9 t -39.17 -44.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.702 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -62.88 -51.37 67.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.998 -1.063 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 m -55.93 -31.12 62.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 110.986 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.512 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mmmm -97.33 -14.71 21.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 111.475 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.723 ' HG3' HD11 ' A' ' 51' ' ' LEU . 4.2 mmt -99.13 -12.77 20.19 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.582 -1.324 . . . . 0.0 109.788 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 20.3 ptmt -77.81 -25.39 0.48 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.671 -0.643 . . . . 0.0 110.71 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 37.2 Cg_endo -83.42 -23.3 3.49 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.739 1.626 . . . . 0.0 108.396 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.3 m -70.79 -5.93 33.93 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.57 0.7 . . . . 0.0 109.232 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.661 HD22 HD11 ' A' ' 58' ' ' ILE . 58.8 mt -66.7 -44.38 81.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.571 -0.706 . . . . 0.0 109.859 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -56.52 -25.08 50.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.849 -1.157 . . . . 0.0 109.749 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 3.9 t80 -89.0 -68.82 0.75 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 109.467 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' A' ' 65' ' ' ASN . 5.4 m -49.43 -24.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 110.937 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 1.089 ' NE2' HG23 ' A' ' 58' ' ' ILE . 3.3 pt20 -118.38 -44.36 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.871 -1.143 . . . . 0.0 110.311 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -58.0 -43.37 95.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 120.16 -45.52 1.23 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 36.0 Cg_endo -79.01 133.78 11.32 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.014 1.809 . . . . 0.0 110.65 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.35 -167.21 23.91 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.436 ' HG2' ' HE3' ' A' ' 72' ' ' LYS . 35.7 Cg_endo -77.14 175.04 49.89 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.145 -1.606 . . . . 0.0 110.472 -0.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.97 13.23 25.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.47 -48.64 3.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 1.2 pp20? -62.88 -18.88 63.57 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.338 -1.096 . . . . 0.0 109.297 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.75 -56.58 7.62 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.065 -1.022 . . . . 0.0 108.88 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.762 ' HA ' HG22 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -65.38 -33.82 76.87 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.37 -0.831 . . . . 0.0 109.067 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -74.27 -21.23 59.85 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.004 -1.06 . . . . 0.0 108.141 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.18 -52.24 7.96 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 69' ' ' ILE . 13.0 t -60.14 -36.96 71.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.618 ' HA ' HG11 ' A' ' 75' ' ' VAL . 5.9 ttp-105 -64.81 -32.27 73.88 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 12.6 t0 -55.58 -46.08 77.3 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.734 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.6 mp -57.88 -43.81 86.28 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -48.78 -43.7 38.2 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.634 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -79.59 -26.35 41.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.78 -72.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.825 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -63.29 136.8 57.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.938 ' HB3' HD13 ' A' ' 90' ' ' ILE . 5.0 mpt_? -65.17 -44.08 89.67 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.943 -1.098 . . . . 0.0 108.59 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.646 ' OE1' HD12 ' A' ' 90' ' ' ILE . 11.5 mm100 -29.65 -60.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.136 0.494 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.813 HG23 ' N ' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -53.22 -58.18 7.94 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 6' ' ' VAL . 98.3 t -58.13 -78.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.565 0.698 . . . . 0.0 110.889 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 46.9 t -40.66 -61.05 1.0 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.506 -0.746 . . . . 0.0 110.068 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 58.7 m-20 -46.38 -42.33 14.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.99 . . . . 0.0 108.965 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -58.59 -69.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 108.599 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HG3' ' A' ' 10' ' ' MET . 8.6 mp -43.32 -26.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.209 -0.932 . . . . 0.0 110.09 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -71.47 -63.78 1.05 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 108.736 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.11 -54.48 25.95 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 7' ' ' ASP . 42.9 mt -53.53 -66.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 109.108 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB1' ' CA ' ' A' ' 82' ' ' SER . . . -51.23 -20.94 1.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.802 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 1.4 tmm_? -98.69 50.29 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.315 -0.866 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.67 25.53 0.58 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.089 HG23 ' NE2' ' A' ' 18' ' ' GLN . 12.8 mt -114.1 153.9 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.992 -0.711 . . . . 0.0 109.5 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.14 -62.55 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.907 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.95 72.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.978 HD22 ' CD ' ' A' ' 83' ' ' PRO . 1.7 tt -48.22 149.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.85 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -109.06 120.0 41.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.812 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -68.73 -36.64 78.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.44 -56.32 17.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.479 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.637 ' ND2' ' CE1' ' A' ' 16' ' ' TYR . 14.6 m120 -64.97 -41.07 95.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.857 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -79.57 5.17 13.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.469 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -113.54 2.64 15.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.298 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.5 t -115.81 0.35 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 110.192 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.62 -49.34 93.24 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.989 -1.07 . . . . 0.0 109.493 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.686 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.4 Cg_endo -78.61 -42.09 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.382 2.055 . . . . 0.0 110.273 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -60.03 -21.55 61.52 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.151 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HE3' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -93.43 -54.69 3.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.9 -0.15 20.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.025 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 50.86 45.83 26.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -93.06 -38.65 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.06 -1.025 . . . . 0.0 109.392 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER 75.08 42.33 0.26 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.767 -0.583 . . . . 0.0 110.836 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.102 HG22 ' HD2' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -79.65 161.84 65.23 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 1.102 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -89.63 -35.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.743 1.629 . . . . 0.0 109.547 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.588 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.3 p90 -98.43 179.11 4.82 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.732 ' H ' HG21 ' A' ' 85' ' ' ILE . 27.2 p -160.86 171.5 18.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -0.975 . . . . 0.0 108.434 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.647 ' O ' ' CG1' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -79.95 83.4 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 123.133 1.444 . . . . 0.0 107.163 178.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.634 ' CA ' ' HB1' ' A' ' 55' ' ' ALA . 1.2 t -151.71 160.84 31.05 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.198 -0.938 . . . . 0.0 109.406 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.978 ' CD ' HD22 ' A' ' 61' ' ' LEU . 37.2 Cg_endo -85.23 26.19 0.66 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.48 2.12 . . . . 0.0 110.188 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' ILE . 40.2 t0 -148.58 -12.44 0.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.781 -1.199 . . . . 0.0 112.407 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -52.46 -178.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.15 -1.594 . . . . 0.0 109.066 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -136.06 119.74 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.508 ' HA ' ' CG1' ' A' ' 90' ' ' ILE . 19.0 m -93.22 -25.15 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.412 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -13.18 55.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.885 . . . . 0.0 109.554 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.88 46.11 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.938 HD13 ' HB3' ' A' ' 44' ' ' ARG . 47.2 mt -83.79 106.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.171 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.465 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.451 0.643 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 1.1 t -82.97 -31.75 27.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.194 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.95 -66.17 2.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -56.03 -62.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.082 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 47' ' ' VAL . 99.2 t -40.66 -31.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.533 -0.73 . . . . 0.0 109.482 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.784 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -73.9 -63.32 1.24 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 108.826 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 8.9 t -49.54 -19.88 0.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -97.34 -29.85 13.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.979 -1.076 . . . . 0.0 110.658 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.889 ' CG ' HD22 ' A' ' 51' ' ' LEU . 1.5 mmm -98.03 -3.17 38.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.747 -1.221 . . . . 0.0 110.739 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.763 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -86.3 -21.71 0.28 Allowed Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 110.338 177.14 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 35.1 Cg_endo -79.55 -4.38 13.53 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 107.649 -1.712 . . . . 0.0 107.649 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -86.67 0.56 54.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.716 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -57.77 -67.06 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.242 -0.911 . . . . 0.0 109.96 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -39.49 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 110.662 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HD2' HG13 ' A' ' 17' ' ' VAL . 8.3 t80 -81.12 -60.75 2.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.667 -1.271 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 ' N ' ' A' ' 18' ' ' GLN . 25.8 m -64.06 -49.68 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.207 -0.933 . . . . 0.0 111.355 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.647 ' HB3' HG21 ' A' ' 58' ' ' ILE . 1.1 pt20 -91.12 4.97 50.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.906 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -112.07 -56.17 0.46 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.896 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 125.05 -49.44 0.91 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.8 Cg_endo -78.56 115.83 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.221 1.947 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.72 -165.15 29.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 35.1 Cg_endo -79.13 -177.84 22.04 Favored 'Cis proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.125 -1.614 . . . . 0.0 110.48 0.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -86.16 13.56 7.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.218 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.79 3.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 23' ' ' PRO . 1.3 m -60.45 -55.24 35.89 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 29' ' ' ASN . 1.6 p -65.56 -43.12 90.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.616 ' C ' ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -62.29 -20.6 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.555 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.76 -56.38 4.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.665 ' HA ' HD22 ' A' ' 34' ' ' LEU . 16.4 t -53.94 -51.29 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.396 . . . . 0.0 108.734 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.626 ' HG3' HG13 ' A' ' 75' ' ' VAL . 10.7 ttt85 -57.79 -30.44 65.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 33.6 t0 -57.87 -46.65 84.55 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.738 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -55.09 -36.69 65.92 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -56.55 -47.17 80.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.965 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.88 -28.7 64.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -81.11 -76.79 0.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.184 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -51.7 139.54 20.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.781 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 73.6 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.906 0.384 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.819 ' CB ' HG21 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.98 -59.03 2.91 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.87 -1.144 . . . . 0.0 109.769 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -30.51 -37.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.672 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.694 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -66.99 -58.16 5.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.738 ' CG1' HD23 ' A' ' 34' ' ' LEU . 94.7 t -57.04 -58.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 109.952 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 16.9 t -47.02 -49.93 20.25 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.1 m-80 -52.95 -40.56 63.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -63.09 -67.51 0.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.775 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.889 HD22 ' CG ' ' A' ' 10' ' ' MET . 1.9 mt -46.57 -24.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.829 -1.169 . . . . 0.0 108.993 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 16.1 tttm -76.04 -44.56 38.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -63.01 -33.68 87.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.784 HD11 ' HA ' ' A' ' 7' ' ' ASP . 26.4 mt -73.35 -59.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.443 -1.034 . . . . 0.0 109.382 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 82' ' ' SER . . . -57.06 -24.17 51.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.357 -0.839 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.9 36.81 0.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.839 -1.163 . . . . 0.0 109.66 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.88 30.48 2.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.109 -2.397 . . . . 0.0 107.109 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.647 HG21 ' HB3' ' A' ' 18' ' ' GLN . 4.3 mm -110.34 156.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.46 0.648 . . . . 0.0 110.152 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -97.72 -26.79 14.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -146.2 46.69 1.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.74 . . . . 0.0 109.059 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' A' ' 83' ' ' PRO . 2.2 tp -57.0 128.76 38.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -85.49 122.74 30.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.5 mm? -71.56 -33.99 69.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.698 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.63 -53.15 60.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.025 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 39.0 m-80 -64.18 -39.9 94.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.672 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -77.41 -5.04 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 0.0 109.345 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -114.35 15.52 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 14.1 t -129.31 10.63 5.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.672 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -64.46 -51.74 57.9 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 0.0 109.286 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.669 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.1 Cg_endo -77.71 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.315 2.01 . . . . 0.0 109.758 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.75 -23.96 67.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.118 -0.988 . . . . 0.0 108.982 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 68' ' ' SER . 4.4 tptp -85.59 -53.9 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 110.557 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 1.0 OUTLIER -87.57 4.81 42.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.853 -1.155 . . . . 0.0 110.604 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 2.4 m-80 64.16 66.15 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.218 -0.926 . . . . 0.0 111.132 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HG3' ' A' ' 32' ' ' ARG . 2.8 t -118.85 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -84.72 36.88 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.035 -1.041 . . . . 0.0 110.655 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 79' ' ' TYR . 1.6 p -79.21 141.78 58.27 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.817 -1.177 . . . . 0.0 108.305 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.958 ' CG ' HG23 ' A' ' 90' ' ' ILE . 36.9 Cg_endo -87.09 -35.03 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.422 2.081 . . . . 0.0 108.352 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 17.2 p90 -96.72 173.86 7.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.714 ' H ' HG21 ' A' ' 85' ' ' ILE . 2.8 p -157.31 -171.42 3.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.904 -1.123 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' CD1' ' A' ' 69' ' ' ILE . 1.7 tp -82.9 71.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.576 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -157.45 154.64 25.91 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' HD22 ' A' ' 61' ' ' LEU . 37.1 Cg_endo -83.87 12.43 3.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.755 2.303 . . . . 0.0 110.286 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.64 -7.08 8.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 0.0 110.175 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.714 HG21 ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -55.78 -172.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -0.984 . . . . 0.0 110.334 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -140.8 113.82 8.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 109.391 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HA ' HD11 ' A' ' 90' ' ' ILE . 5.7 m -87.24 -23.99 24.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.197 -0.939 . . . . 0.0 109.668 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 -23.32 55.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.609 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.95 34.87 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.456 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.958 HG23 ' CG ' ' A' ' 78' ' ' PRO . 74.8 mt -90.12 127.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.45 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 13.6 t -99.42 -11.67 20.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.15 -60.48 8.79 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -56.3 -57.91 10.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' CG ' ' A' ' 10' ' ' MET . 46.9 t -48.04 -36.5 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.95 -47.18 63.38 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.008 -1.058 . . . . 0.0 110.497 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.49 -30.46 71.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 0.0 111.404 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -96.27 -17.1 20.98 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.949 -1.094 . . . . 0.0 110.189 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.55 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 18.0 mmt -97.89 -14.98 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.85 -1.157 . . . . 0.0 109.456 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.716 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.91 -28.47 0.9 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 111.184 178.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 36.1 Cg_endo -79.15 -17.86 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.942 ' O ' HG22 ' A' ' 17' ' ' VAL . 19.1 m -74.04 -4.28 34.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 54' ' ' ILE . 33.8 mt -73.35 -36.1 66.08 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.478 -0.764 . . . . 0.0 109.632 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.68 -32.41 71.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.944 -1.098 . . . . 0.0 109.352 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 1.9 t80 -85.26 -66.69 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.146 -0.971 . . . . 0.0 109.056 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.037 HG21 ' CD1' ' A' ' 81' ' ' ILE . 34.3 m -51.54 -20.42 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.284 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.653 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -118.92 -51.4 2.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . -60.31 -43.04 98.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.624 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 121.22 -44.93 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.998 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.0 Cg_endo -77.46 120.61 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.992 1.795 . . . . 0.0 110.844 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 149.7 -168.45 29.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.3 173.29 58.85 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.238 -1.568 . . . . 0.0 110.483 0.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 m -90.84 11.15 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.613 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.99 -47.84 3.19 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -68.21 -20.44 64.84 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.3 -1.118 . . . . 0.0 109.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 m -63.5 -61.97 1.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.02 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . 21.6 p -68.94 -31.86 71.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.37 -0.832 . . . . 0.0 110.05 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 30' ' ' GLY . 1.3 p-10 -71.72 -21.81 61.72 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.674 -1.266 . . . . 0.0 107.941 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -79.91 -50.3 5.62 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.766 ' HA ' HD22 ' A' ' 34' ' ' LEU . 42.3 t -59.83 -45.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.247 . . . . 0.0 108.702 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -58.15 -28.0 64.3 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 9.8 t70 -66.08 -46.89 76.08 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.798 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.5 mp -53.05 -28.9 26.88 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -64.47 -60.38 3.21 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -54.3 -22.73 12.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 108.672 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -80.95 -35.17 32.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.609 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.608 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -71.12 111.44 6.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.229 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 110.303 -179.417 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.974 ' HB3' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 -27.79 16.99 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 7.6 mp0 -59.51 -46.99 87.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.04 -1.037 . . . . 0.0 108.689 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -65.46 -71.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.8 ' N ' HG22 ' A' ' 46' ' ' THR . 24.6 t -44.74 -61.1 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.716 0.77 . . . . 0.0 110.59 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 43.7 t -48.03 -54.7 12.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.693 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.3 m120 -53.83 -29.74 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.086 -1.009 . . . . 0.0 109.135 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 89.9 m -73.32 -70.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.487 -0.758 . . . . 0.0 109.97 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 51' ' ' LEU . 3.3 mt -41.5 -37.18 1.03 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 5.2 tttm -70.59 -45.48 65.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 108.809 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -55.07 -28.78 50.19 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.67 HG22 HD21 ' A' ' 14' ' ' LEU . 19.1 mt -83.92 -70.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -1.099 . . . . 0.0 108.51 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -36.91 -29.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.789 -0.569 . . . . 0.0 110.553 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -85.45 47.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.554 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.34 26.06 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.977 HD12 HD12 ' A' ' 61' ' ' LEU . 28.2 mt -115.1 160.63 14.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 122.027 -0.69 . . . . 0.0 109.514 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.407 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 14.2 m80 -84.06 -61.63 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.935 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.86 63.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 108.945 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 58' ' ' ILE . 1.4 tt -60.56 129.24 40.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 110.032 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.8 121.69 27.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 109.412 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.9 mm? -82.9 4.5 25.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 108.763 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.25 -53.05 4.26 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 16' ' ' TYR . 11.4 m120 -67.78 -39.9 84.04 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -75.31 0.47 16.59 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.358 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . -121.04 -2.97 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 109.858 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 4.2 t -112.83 6.0 17.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.722 HD13 ' HB ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -62.25 -50.07 81.47 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.001 -1.062 . . . . 0.0 110.198 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.698 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.6 Cg_endo -76.45 -53.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.301 2.001 . . . . 0.0 110.731 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -27.8 66.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.667 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -80.02 -55.82 4.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.984 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -76.82 -1.73 29.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.371 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 1.4 m-20 69.48 34.44 2.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.842 . . . . 0.0 111.54 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 76' ' ' ASN . 4.7 t -79.96 -129.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.54 -1.35 . . . . 0.0 107.884 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' HG12 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -176.55 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.744 -1.222 . . . . 0.0 109.837 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.766 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -85.49 145.89 43.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.933 ' HG2' HG23 ' A' ' 90' ' ' ILE . 36.4 Cg_endo -86.84 -33.78 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.078 1.852 . . . . 0.0 108.331 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.68 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p90 -99.44 163.86 12.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.111 0.957 . . . . 0.0 110.776 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.851 ' H ' HG21 ' A' ' 85' ' ' ILE . 64.6 p -161.33 165.6 28.82 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.037 ' CD1' HG21 ' A' ' 17' ' ' VAL . 1.4 pp -54.77 94.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 117.587 -1.645 . . . . 0.0 107.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.66 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 29.3 t -172.5 142.78 1.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.045 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.4 8.34 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.723 2.282 . . . . 0.0 110.173 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.74 -16.35 14.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.348 -0.845 . . . . 0.0 110.208 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.851 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -71.49 170.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.908 -1.12 . . . . 0.0 109.933 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -117.31 119.01 33.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.764 ' HA ' HD11 ' A' ' 90' ' ' ILE . 81.7 m -95.67 -17.25 21.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.17 -0.956 . . . . 0.0 109.821 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.98 -4.98 38.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.081 -1.012 . . . . 0.0 109.413 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 34.42 5.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.974 HD13 ' HB3' ' A' ' 44' ' ' ARG . 5.0 mt -86.18 115.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.103 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.489 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 1.7 t -75.97 -25.25 55.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.51 -66.94 2.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -58.01 9.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -1.191 . . . . 0.0 109.034 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.622 ' CG1' HD21 ' A' ' 51' ' ' LEU . 93.9 t -44.81 -27.77 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -76.4 -53.56 7.97 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -58.21 -27.53 63.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -0.823 . . . . 0.0 111.418 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 26.0 mttm -97.51 -28.31 14.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 110.804 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.677 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.66 -2.26 38.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.659 -1.276 . . . . 0.0 110.665 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.797 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -84.07 -21.5 0.29 Allowed Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.24 176.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.797 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 34.9 Cg_endo -79.84 -12.88 13.29 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.2 m -80.57 -2.2 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.87 HD21 HG22 ' A' ' 54' ' ' ILE . 26.4 mt -73.37 -58.61 3.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.488 -0.758 . . . . 0.0 109.799 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -51.82 -18.0 1.14 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.921 -1.112 . . . . 0.0 110.277 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG13 ' A' ' 17' ' ' VAL . 2.2 t80 -90.45 -63.3 1.29 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.875 -1.141 . . . . 0.0 109.814 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 13' ' ' CYS . 35.9 m -54.86 -30.59 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 111.273 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.718 ' CG ' HD13 ' A' ' 58' ' ' ILE . 3.7 pt20 -112.92 -20.15 11.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.751 -1.218 . . . . 0.0 110.627 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -86.64 -46.99 5.0 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.099 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 130.99 -49.74 0.92 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.4 Cg_endo -78.38 144.79 20.69 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.292 1.995 . . . . 0.0 110.957 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.81 -165.27 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 176.14 45.23 Favored 'Cis proline' 0 C--N 1.308 -1.556 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.305 0.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -86.92 155.51 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.301 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.67 83.78 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.495 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -57.59 -40.6 79.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.37 -1.077 . . . . 0.0 109.391 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -48.46 -41.31 29.16 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.918 -1.114 . . . . 0.0 108.822 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 m -77.93 -36.53 49.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 109.778 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 4.9 p-10 -73.62 -7.27 51.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.982 -1.074 . . . . 0.0 108.79 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -98.87 -54.94 1.09 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' HD22 ' A' ' 34' ' ' LEU . 13.9 t -59.94 -37.72 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.095 -1.238 . . . . 0.0 107.755 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.558 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.4 ttm-85 -61.94 -32.64 73.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 10.6 t70 -61.0 -47.06 88.19 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 ' CG1' ' A' ' 47' ' ' VAL . 2.1 mp -55.03 -34.15 63.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.91 -73.89 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.297 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -53.89 -21.86 8.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.348 -0.845 . . . . 0.0 110.879 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 17.6 mm100 -79.56 -35.2 40.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.901 -1.125 . . . . 0.0 109.243 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -63.25 131.09 47.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.795 -179.477 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' CE2' ' A' ' 79' ' ' TYR . 1.7 mpt_? -88.27 -59.57 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.576 ' C ' ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -23.08 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.14 0.495 . . . . 0.0 110.299 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.672 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -61.73 -57.88 10.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 108.721 178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.727 ' CG1' HD23 ' A' ' 34' ' ' LEU . 63.4 t -63.26 -72.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.532 0.682 . . . . 0.0 110.323 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -39.39 -55.11 1.81 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 93.7 m-20 -50.87 -46.56 60.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.405 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 33.7 m -54.74 -65.06 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.922 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.677 HD22 ' CB ' ' A' ' 10' ' ' MET . 3.2 mt -44.83 -30.14 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.424 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.999 ' HB2' HD11 ' A' ' 85' ' ' ILE . 55.3 tttt -69.34 -52.08 30.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.99 -43.54 82.83 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.87 HG22 HD21 ' A' ' 14' ' ' LEU . 51.8 mt -61.97 -63.68 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 0.0 108.777 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.768 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -50.19 -22.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -91.73 49.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.099 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.65 23.49 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.718 HD13 ' CG ' ' A' ' 18' ' ' GLN . 14.7 mt -116.75 152.38 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -92.87 -23.05 18.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 109.741 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.71 70.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.692 HD12 HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -80.68 146.01 31.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 1.6 t-20 -108.72 121.36 44.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.108 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.671 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 5.0 mt -81.35 1.61 31.97 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -89.7 -55.95 3.44 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 4.8 m120 -68.89 -32.66 72.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.925 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -80.21 8.43 7.35 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.689 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 63' ' ' LEU . . . -113.32 -12.98 12.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.084 -1.01 . . . . 0.0 109.065 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -114.22 13.67 17.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 109.762 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.925 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.05 -47.47 98.42 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.075 -1.016 . . . . 0.0 109.9 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.666 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.6 Cg_endo -78.84 -64.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.18 1.92 . . . . 0.0 110.458 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' PRO . 1.4 t -44.46 -26.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' SER . 3.4 tppt? -93.22 -35.76 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HB3' HG22 ' A' ' 75' ' ' VAL . 18.0 m -82.45 2.75 31.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.73 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 52.82 35.29 18.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.416 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -101.76 -31.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 109.084 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 68.33 26.69 6.74 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.725 -0.61 . . . . 0.0 110.081 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.869 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.1 p -79.56 147.77 68.33 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.869 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -86.95 -38.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.296 1.997 . . . . 0.0 108.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.6 p90 -94.14 152.09 19.0 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.832 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.903 ' H ' HG21 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -160.75 163.54 32.22 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.768 ' C ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -51.62 92.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.806 -1.184 . . . . 0.0 108.737 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.562 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 2.4 t -159.33 156.2 25.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 120.891 -1.131 . . . . 0.0 109.693 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' HD22 ' A' ' 61' ' ' LEU . 38.5 Cg_endo -87.7 23.34 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.014 2.476 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 13.5 t70 -149.71 5.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 111.423 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -69.76 -177.86 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.664 -1.272 . . . . 0.0 110.265 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' HG2' ' A' ' 89' ' ' ARG . 38.0 t0 -145.8 125.9 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.957 ' HA ' HD11 ' A' ' 90' ' ' ILE . 1.9 m -89.78 -3.98 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.7 15.86 22.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.277 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.46 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 18.5 mmt180 -116.94 4.93 12.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.031 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -102.51 133.32 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.29 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.483 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.768 0.794 . . . . 0.0 109.776 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.66 ' CG ' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -127.13 -18.79 4.49 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.744 -0.597 . . . . 0.0 110.183 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.813 ' N ' HG23 ' A' ' 46' ' ' THR . 0.5 OUTLIER -53.99 -31.99 52.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 108.694 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . . . -66.46 -53.8 26.6 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' VAL . 1.9 tt0 -62.35 -62.46 1.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.076 -1.25 . . . . 0.0 108.249 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 47' ' ' VAL . 88.9 t -39.17 -44.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.702 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -62.88 -51.37 67.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.998 -1.063 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 m -55.93 -31.12 62.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 110.986 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.512 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mmmm -97.33 -14.71 21.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 111.475 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.723 ' HG3' HD11 ' A' ' 51' ' ' LEU . 4.2 mmt -99.13 -12.77 20.19 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.582 -1.324 . . . . 0.0 109.788 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 20.3 ptmt -77.81 -25.39 0.48 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.671 -0.643 . . . . 0.0 110.71 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 37.2 Cg_endo -83.42 -23.3 3.49 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.739 1.626 . . . . 0.0 108.396 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.3 m -70.79 -5.93 33.93 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.57 0.7 . . . . 0.0 109.232 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.661 HD22 HD11 ' A' ' 58' ' ' ILE . 58.8 mt -66.7 -44.38 81.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.571 -0.706 . . . . 0.0 109.859 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -56.52 -25.08 50.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.849 -1.157 . . . . 0.0 109.749 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 3.9 t80 -89.0 -68.82 0.75 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 109.467 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' A' ' 65' ' ' ASN . 5.4 m -49.43 -24.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 110.937 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 1.089 ' NE2' HG23 ' A' ' 58' ' ' ILE . 3.3 pt20 -118.38 -44.36 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.871 -1.143 . . . . 0.0 110.311 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -58.0 -43.37 95.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 120.16 -45.52 1.23 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 36.0 Cg_endo -79.01 133.78 11.32 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.014 1.809 . . . . 0.0 110.65 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.35 -167.21 23.91 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.436 ' HG2' ' HE3' ' A' ' 72' ' ' LYS . 35.7 Cg_endo -77.14 175.04 49.89 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.145 -1.606 . . . . 0.0 110.472 -0.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.97 13.23 25.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.47 -48.64 3.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 1.2 pp20? -62.88 -18.88 63.57 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.338 -1.096 . . . . 0.0 109.297 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.75 -56.58 7.62 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.065 -1.022 . . . . 0.0 108.88 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.762 ' HA ' HG22 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -65.38 -33.82 76.87 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.37 -0.831 . . . . 0.0 109.067 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -74.27 -21.23 59.85 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.004 -1.06 . . . . 0.0 108.141 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.18 -52.24 7.96 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 69' ' ' ILE . 13.0 t -60.14 -36.96 71.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.618 ' HA ' HG11 ' A' ' 75' ' ' VAL . 5.9 ttp-105 -64.81 -32.27 73.88 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 12.6 t0 -55.58 -46.08 77.3 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.734 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.6 mp -57.88 -43.81 86.28 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.539 ' CE1' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -48.78 -43.7 38.2 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.634 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -79.59 -26.35 41.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.78 -72.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.825 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -63.29 136.8 57.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -118.07 -37.96 3.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -114.64 176.17 5.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.033 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -60.41 -50.49 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.143 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.0 -19.42 5.34 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -87.04 -35.85 18.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -1.17 . . . . 0.0 109.493 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.938 ' HB3' HD13 ' A' ' 90' ' ' ILE . 5.0 mpt_? -65.17 -44.08 89.67 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.943 -1.098 . . . . 0.0 108.59 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.646 ' OE1' HD12 ' A' ' 90' ' ' ILE . 11.5 mm100 -29.65 -60.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.136 0.494 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.813 HG23 ' N ' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -53.22 -58.18 7.94 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 6' ' ' VAL . 98.3 t -58.13 -78.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.565 0.698 . . . . 0.0 110.889 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 46.9 t -40.66 -61.05 1.0 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.506 -0.746 . . . . 0.0 110.068 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 58.7 m-20 -46.38 -42.33 14.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.99 . . . . 0.0 108.965 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -58.59 -69.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 108.599 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HG3' ' A' ' 10' ' ' MET . 8.6 mp -43.32 -26.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.209 -0.932 . . . . 0.0 110.09 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -71.47 -63.78 1.05 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 108.736 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.11 -54.48 25.95 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 7' ' ' ASP . 42.9 mt -53.53 -66.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 109.108 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB1' ' CA ' ' A' ' 82' ' ' SER . . . -51.23 -20.94 1.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.802 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 1.4 tmm_? -98.69 50.29 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.315 -0.866 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.67 25.53 0.58 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.089 HG23 ' NE2' ' A' ' 18' ' ' GLN . 12.8 mt -114.1 153.9 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.992 -0.711 . . . . 0.0 109.5 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.14 -62.55 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.907 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.95 72.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.978 HD22 ' CD ' ' A' ' 83' ' ' PRO . 1.7 tt -48.22 149.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.85 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -109.06 120.0 41.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.812 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -68.73 -36.64 78.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.44 -56.32 17.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.479 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.637 ' ND2' ' CE1' ' A' ' 16' ' ' TYR . 14.6 m120 -64.97 -41.07 95.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.857 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -79.57 5.17 13.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.469 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -113.54 2.64 15.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.298 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.5 t -115.81 0.35 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 110.192 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.62 -49.34 93.24 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.989 -1.07 . . . . 0.0 109.493 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.686 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.4 Cg_endo -78.61 -42.09 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.382 2.055 . . . . 0.0 110.273 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -60.03 -21.55 61.52 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.151 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HE3' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -93.43 -54.69 3.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.9 -0.15 20.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.025 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 50.86 45.83 26.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -93.06 -38.65 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.06 -1.025 . . . . 0.0 109.392 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER 75.08 42.33 0.26 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.767 -0.583 . . . . 0.0 110.836 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.102 HG22 ' HD2' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -79.65 161.84 65.23 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 1.102 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -89.63 -35.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.743 1.629 . . . . 0.0 109.547 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.588 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.3 p90 -98.43 179.11 4.82 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.732 ' H ' HG21 ' A' ' 85' ' ' ILE . 27.2 p -160.86 171.5 18.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -0.975 . . . . 0.0 108.434 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.647 ' O ' ' CG1' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -79.95 83.4 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 123.133 1.444 . . . . 0.0 107.163 178.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.634 ' CA ' ' HB1' ' A' ' 55' ' ' ALA . 1.2 t -151.71 160.84 31.05 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.198 -0.938 . . . . 0.0 109.406 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.978 ' CD ' HD22 ' A' ' 61' ' ' LEU . 37.2 Cg_endo -85.23 26.19 0.66 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.48 2.12 . . . . 0.0 110.188 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' ILE . 40.2 t0 -148.58 -12.44 0.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.781 -1.199 . . . . 0.0 112.407 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -52.46 -178.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.15 -1.594 . . . . 0.0 109.066 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -136.06 119.74 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.508 ' HA ' ' CG1' ' A' ' 90' ' ' ILE . 19.0 m -93.22 -25.15 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.412 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -13.18 55.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.885 . . . . 0.0 109.554 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.88 46.11 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.938 HD13 ' HB3' ' A' ' 44' ' ' ARG . 47.2 mt -83.79 106.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.171 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.465 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.802 HD13 ' N ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.204 0.526 . . . . 0.0 109.608 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -158.13 -173.55 4.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.867 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 1.1 t -82.97 -31.75 27.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.194 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.95 -66.17 2.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -56.03 -62.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.082 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 47' ' ' VAL . 99.2 t -40.66 -31.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.533 -0.73 . . . . 0.0 109.482 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.784 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -73.9 -63.32 1.24 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 108.826 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 8.9 t -49.54 -19.88 0.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -97.34 -29.85 13.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.979 -1.076 . . . . 0.0 110.658 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.889 ' CG ' HD22 ' A' ' 51' ' ' LEU . 1.5 mmm -98.03 -3.17 38.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.747 -1.221 . . . . 0.0 110.739 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.763 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -86.3 -21.71 0.28 Allowed Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 110.338 177.14 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 35.1 Cg_endo -79.55 -4.38 13.53 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 107.649 -1.712 . . . . 0.0 107.649 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -86.67 0.56 54.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.716 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -57.77 -67.06 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.242 -0.911 . . . . 0.0 109.96 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -39.49 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 110.662 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HD2' HG13 ' A' ' 17' ' ' VAL . 8.3 t80 -81.12 -60.75 2.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.667 -1.271 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 ' N ' ' A' ' 18' ' ' GLN . 25.8 m -64.06 -49.68 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.207 -0.933 . . . . 0.0 111.355 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.647 ' HB3' HG21 ' A' ' 58' ' ' ILE . 1.1 pt20 -91.12 4.97 50.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.906 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -112.07 -56.17 0.46 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.896 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 125.05 -49.44 0.91 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.8 Cg_endo -78.56 115.83 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.221 1.947 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.72 -165.15 29.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 35.1 Cg_endo -79.13 -177.84 22.04 Favored 'Cis proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.125 -1.614 . . . . 0.0 110.48 0.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -86.16 13.56 7.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.218 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.79 3.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 23' ' ' PRO . 1.3 m -60.45 -55.24 35.89 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 29' ' ' ASN . 1.6 p -65.56 -43.12 90.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.616 ' C ' ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -62.29 -20.6 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.555 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.76 -56.38 4.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.665 ' HA ' HD22 ' A' ' 34' ' ' LEU . 16.4 t -53.94 -51.29 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.396 . . . . 0.0 108.734 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.626 ' HG3' HG13 ' A' ' 75' ' ' VAL . 10.7 ttt85 -57.79 -30.44 65.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 33.6 t0 -57.87 -46.65 84.55 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.738 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -55.09 -36.69 65.92 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -56.55 -47.17 80.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.965 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.88 -28.7 64.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' HB3' HD12 ' A' ' 1' ' ' LEU . 16.9 mt-30 -81.11 -76.79 0.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.184 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -51.7 139.54 20.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -65.66 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.781 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 2.8 m -101.26 -164.36 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -72.91 -24.17 60.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.67 1.1 39.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 73.6 m-20 -121.55 -29.09 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.24 . . . . 0.0 110.041 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.819 ' CB ' HG21 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.98 -59.03 2.91 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.87 -1.144 . . . . 0.0 109.769 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -30.51 -37.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.672 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.694 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -66.99 -58.16 5.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.738 ' CG1' HD23 ' A' ' 34' ' ' LEU . 94.7 t -57.04 -58.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 109.952 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 16.9 t -47.02 -49.93 20.25 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.1 m-80 -52.95 -40.56 63.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -63.09 -67.51 0.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.775 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.889 HD22 ' CG ' ' A' ' 10' ' ' MET . 1.9 mt -46.57 -24.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.829 -1.169 . . . . 0.0 108.993 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 16.1 tttm -76.04 -44.56 38.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -63.01 -33.68 87.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.784 HD11 ' HA ' ' A' ' 7' ' ' ASP . 26.4 mt -73.35 -59.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.443 -1.034 . . . . 0.0 109.382 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 82' ' ' SER . . . -57.06 -24.17 51.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.357 -0.839 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.9 36.81 0.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.839 -1.163 . . . . 0.0 109.66 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.88 30.48 2.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.109 -2.397 . . . . 0.0 107.109 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.647 HG21 ' HB3' ' A' ' 18' ' ' GLN . 4.3 mm -110.34 156.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.46 0.648 . . . . 0.0 110.152 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -97.72 -26.79 14.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -146.2 46.69 1.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.74 . . . . 0.0 109.059 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' A' ' 83' ' ' PRO . 2.2 tp -57.0 128.76 38.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -85.49 122.74 30.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.5 mm? -71.56 -33.99 69.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.698 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.63 -53.15 60.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.025 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 39.0 m-80 -64.18 -39.9 94.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.672 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -77.41 -5.04 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 0.0 109.345 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -114.35 15.52 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 14.1 t -129.31 10.63 5.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.672 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -64.46 -51.74 57.9 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 0.0 109.286 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.669 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.1 Cg_endo -77.71 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.315 2.01 . . . . 0.0 109.758 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.75 -23.96 67.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.118 -0.988 . . . . 0.0 108.982 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 68' ' ' SER . 4.4 tptp -85.59 -53.9 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 110.557 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 1.0 OUTLIER -87.57 4.81 42.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.853 -1.155 . . . . 0.0 110.604 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 2.4 m-80 64.16 66.15 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.218 -0.926 . . . . 0.0 111.132 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HG3' ' A' ' 32' ' ' ARG . 2.8 t -118.85 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -84.72 36.88 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.035 -1.041 . . . . 0.0 110.655 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 79' ' ' TYR . 1.6 p -79.21 141.78 58.27 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.817 -1.177 . . . . 0.0 108.305 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.958 ' CG ' HG23 ' A' ' 90' ' ' ILE . 36.9 Cg_endo -87.09 -35.03 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.422 2.081 . . . . 0.0 108.352 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 17.2 p90 -96.72 173.86 7.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.714 ' H ' HG21 ' A' ' 85' ' ' ILE . 2.8 p -157.31 -171.42 3.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.904 -1.123 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' CD1' ' A' ' 69' ' ' ILE . 1.7 tp -82.9 71.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.576 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -157.45 154.64 25.91 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' HD22 ' A' ' 61' ' ' LEU . 37.1 Cg_endo -83.87 12.43 3.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.755 2.303 . . . . 0.0 110.286 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.64 -7.08 8.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 0.0 110.175 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.714 HG21 ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -55.78 -172.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -0.984 . . . . 0.0 110.334 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -140.8 113.82 8.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 109.391 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HA ' HD11 ' A' ' 90' ' ' ILE . 5.7 m -87.24 -23.99 24.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.197 -0.939 . . . . 0.0 109.668 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 -23.32 55.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.609 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.95 34.87 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.456 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.958 HG23 ' CG ' ' A' ' 78' ' ' PRO . 74.8 mt -90.12 127.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.45 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 2' ' ' ASN . 4.0 pp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.797 ' N ' HD12 ' A' ' 1' ' ' LEU . 0.0 OUTLIER -141.15 -165.76 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 13.6 t -99.42 -11.67 20.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.15 -60.48 8.79 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -56.3 -57.91 10.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' CG ' ' A' ' 10' ' ' MET . 46.9 t -48.04 -36.5 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.95 -47.18 63.38 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.008 -1.058 . . . . 0.0 110.497 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.49 -30.46 71.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 0.0 111.404 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -96.27 -17.1 20.98 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.949 -1.094 . . . . 0.0 110.189 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.55 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 18.0 mmt -97.89 -14.98 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.85 -1.157 . . . . 0.0 109.456 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.716 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.91 -28.47 0.9 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 111.184 178.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 36.1 Cg_endo -79.15 -17.86 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.942 ' O ' HG22 ' A' ' 17' ' ' VAL . 19.1 m -74.04 -4.28 34.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 54' ' ' ILE . 33.8 mt -73.35 -36.1 66.08 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.478 -0.764 . . . . 0.0 109.632 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.68 -32.41 71.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.944 -1.098 . . . . 0.0 109.352 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 1.9 t80 -85.26 -66.69 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.146 -0.971 . . . . 0.0 109.056 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.037 HG21 ' CD1' ' A' ' 81' ' ' ILE . 34.3 m -51.54 -20.42 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.284 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.653 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -118.92 -51.4 2.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . -60.31 -43.04 98.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.624 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 121.22 -44.93 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.998 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.0 Cg_endo -77.46 120.61 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.992 1.795 . . . . 0.0 110.844 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 149.7 -168.45 29.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.3 173.29 58.85 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.238 -1.568 . . . . 0.0 110.483 0.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 m -90.84 11.15 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.613 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.99 -47.84 3.19 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -68.21 -20.44 64.84 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.3 -1.118 . . . . 0.0 109.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 m -63.5 -61.97 1.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.02 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . 21.6 p -68.94 -31.86 71.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.37 -0.832 . . . . 0.0 110.05 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 30' ' ' GLY . 1.3 p-10 -71.72 -21.81 61.72 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.674 -1.266 . . . . 0.0 107.941 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -79.91 -50.3 5.62 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.766 ' HA ' HD22 ' A' ' 34' ' ' LEU . 42.3 t -59.83 -45.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.247 . . . . 0.0 108.702 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -58.15 -28.0 64.3 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 9.8 t70 -66.08 -46.89 76.08 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.798 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.5 mp -53.05 -28.9 26.88 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -64.47 -60.38 3.21 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -54.3 -22.73 12.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 108.672 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HB3' ' CD2' ' A' ' 1' ' ' LEU . 14.0 mm-40 -80.95 -35.17 32.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.609 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -71.12 111.44 6.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.229 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -151.33 -35.37 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 110.303 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' SER . 45.2 p -78.7 -129.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 108.242 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -43.63 -28.16 0.37 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.784 -1.197 . . . . 0.0 108.058 178.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.695 ' O ' ' HB1' ' A' ' 38' ' ' ALA . . . 149.4 -27.12 1.22 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 56.91 18.52 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.974 ' HB3' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 -27.79 16.99 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 7.6 mp0 -59.51 -46.99 87.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.04 -1.037 . . . . 0.0 108.689 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -65.46 -71.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.8 ' N ' HG22 ' A' ' 46' ' ' THR . 24.6 t -44.74 -61.1 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.716 0.77 . . . . 0.0 110.59 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 43.7 t -48.03 -54.7 12.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.693 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 2.3 m120 -53.83 -29.74 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.086 -1.009 . . . . 0.0 109.135 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 89.9 m -73.32 -70.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.487 -0.758 . . . . 0.0 109.97 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 51' ' ' LEU . 3.3 mt -41.5 -37.18 1.03 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 5.2 tttm -70.59 -45.48 65.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 108.809 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -55.07 -28.78 50.19 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.67 HG22 HD21 ' A' ' 14' ' ' LEU . 19.1 mt -83.92 -70.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -1.099 . . . . 0.0 108.51 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -36.91 -29.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.789 -0.569 . . . . 0.0 110.553 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -85.45 47.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.554 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.34 26.06 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.977 HD12 HD12 ' A' ' 61' ' ' LEU . 28.2 mt -115.1 160.63 14.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 122.027 -0.69 . . . . 0.0 109.514 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.407 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 14.2 m80 -84.06 -61.63 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.935 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -118.86 63.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 108.945 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 58' ' ' ILE . 1.4 tt -60.56 129.24 40.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 110.032 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.8 121.69 27.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 109.412 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.9 mm? -82.9 4.5 25.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 108.763 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -93.25 -53.05 4.26 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.61 ' ND2' ' CE1' ' A' ' 16' ' ' TYR . 11.4 m120 -67.78 -39.9 84.04 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -75.31 0.47 16.59 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.358 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . -121.04 -2.97 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 109.858 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 4.2 t -112.83 6.0 17.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.722 HD13 ' HB ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -62.25 -50.07 81.47 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.001 -1.062 . . . . 0.0 110.198 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.698 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.6 Cg_endo -76.45 -53.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.301 2.001 . . . . 0.0 110.731 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -27.8 66.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.667 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -80.02 -55.82 4.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.984 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -76.82 -1.73 29.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.371 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 1.4 m-20 69.48 34.44 2.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.842 . . . . 0.0 111.54 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 76' ' ' ASN . 4.7 t -79.96 -129.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.54 -1.35 . . . . 0.0 107.884 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' HG12 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -176.55 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.744 -1.222 . . . . 0.0 109.837 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.766 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -85.49 145.89 43.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.933 ' HG2' HG23 ' A' ' 90' ' ' ILE . 36.4 Cg_endo -86.84 -33.78 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.078 1.852 . . . . 0.0 108.331 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.68 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p90 -99.44 163.86 12.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.111 0.957 . . . . 0.0 110.776 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.851 ' H ' HG21 ' A' ' 85' ' ' ILE . 64.6 p -161.33 165.6 28.82 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.037 ' CD1' HG21 ' A' ' 17' ' ' VAL . 1.4 pp -54.77 94.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 117.587 -1.645 . . . . 0.0 107.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.66 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 29.3 t -172.5 142.78 1.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.045 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.4 8.34 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.723 2.282 . . . . 0.0 110.173 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.74 -16.35 14.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.348 -0.845 . . . . 0.0 110.208 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.851 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -71.49 170.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.908 -1.12 . . . . 0.0 109.933 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -117.31 119.01 33.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.764 ' HA ' HD11 ' A' ' 90' ' ' ILE . 81.7 m -95.67 -17.25 21.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.17 -0.956 . . . . 0.0 109.821 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.98 -4.98 38.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.081 -1.012 . . . . 0.0 109.413 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 34.42 5.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.974 HD13 ' HB3' ' A' ' 44' ' ' ARG . 5.0 mt -86.18 115.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.103 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.489 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.381 0.61 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -145.98 -166.58 2.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.098 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 1.7 t -75.97 -25.25 55.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.51 -66.94 2.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -58.01 9.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -1.191 . . . . 0.0 109.034 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.622 ' CG1' HD21 ' A' ' 51' ' ' LEU . 93.9 t -44.81 -27.77 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -76.4 -53.56 7.97 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -58.21 -27.53 63.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -0.823 . . . . 0.0 111.418 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 26.0 mttm -97.51 -28.31 14.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 110.804 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.677 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.66 -2.26 38.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.659 -1.276 . . . . 0.0 110.665 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.797 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -84.07 -21.5 0.29 Allowed Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.24 176.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.797 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 34.9 Cg_endo -79.84 -12.88 13.29 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.2 m -80.57 -2.2 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.87 HD21 HG22 ' A' ' 54' ' ' ILE . 26.4 mt -73.37 -58.61 3.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.488 -0.758 . . . . 0.0 109.799 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -51.82 -18.0 1.14 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.921 -1.112 . . . . 0.0 110.277 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG13 ' A' ' 17' ' ' VAL . 2.2 t80 -90.45 -63.3 1.29 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.875 -1.141 . . . . 0.0 109.814 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 13' ' ' CYS . 35.9 m -54.86 -30.59 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 111.273 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.718 ' CG ' HD13 ' A' ' 58' ' ' ILE . 3.7 pt20 -112.92 -20.15 11.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.751 -1.218 . . . . 0.0 110.627 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -86.64 -46.99 5.0 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.099 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 130.99 -49.74 0.92 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.4 Cg_endo -78.38 144.79 20.69 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.292 1.995 . . . . 0.0 110.957 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.81 -165.27 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 176.14 45.23 Favored 'Cis proline' 0 C--N 1.308 -1.556 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.305 0.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -86.92 155.51 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.301 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.67 83.78 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -57.59 -40.6 79.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.37 -1.077 . . . . 0.0 109.391 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -48.46 -41.31 29.16 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.918 -1.114 . . . . 0.0 108.822 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 m -77.93 -36.53 49.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 109.778 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 4.9 p-10 -73.62 -7.27 51.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.982 -1.074 . . . . 0.0 108.79 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -98.87 -54.94 1.09 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' HD22 ' A' ' 34' ' ' LEU . 13.9 t -59.94 -37.72 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.095 -1.238 . . . . 0.0 107.755 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.558 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.4 ttm-85 -61.94 -32.64 73.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 10.6 t70 -61.0 -47.06 88.19 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 ' CG1' ' A' ' 47' ' ' VAL . 2.1 mp -55.03 -34.15 63.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.91 -73.89 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.297 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -53.89 -21.86 8.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.348 -0.845 . . . . 0.0 110.879 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 17.6 mm100 -79.56 -35.2 40.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.901 -1.125 . . . . 0.0 109.243 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -63.25 131.09 47.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -151.62 -39.01 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.795 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.4 m -79.02 -131.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.847 -1.158 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -45.3 -26.95 0.58 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.74 ' O ' ' HB1' ' A' ' 38' ' ' ALA . . . 152.49 -20.53 0.82 Allowed Glycine 0 C--O 1.208 -1.529 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 58.06 20.52 6.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' CE2' ' A' ' 79' ' ' TYR . 1.7 mpt_? -88.27 -59.57 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.576 ' C ' ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -23.08 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.14 0.495 . . . . 0.0 110.299 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.672 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -61.73 -57.88 10.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 108.721 178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.727 ' CG1' HD23 ' A' ' 34' ' ' LEU . 63.4 t -63.26 -72.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.532 0.682 . . . . 0.0 110.323 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -39.39 -55.11 1.81 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 93.7 m-20 -50.87 -46.56 60.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.405 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 33.7 m -54.74 -65.06 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.922 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.677 HD22 ' CB ' ' A' ' 10' ' ' MET . 3.2 mt -44.83 -30.14 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.424 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.999 ' HB2' HD11 ' A' ' 85' ' ' ILE . 55.3 tttt -69.34 -52.08 30.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.99 -43.54 82.83 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.87 HG22 HD21 ' A' ' 14' ' ' LEU . 51.8 mt -61.97 -63.68 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 0.0 108.777 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.768 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -50.19 -22.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -91.73 49.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.099 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.65 23.49 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.718 HD13 ' CG ' ' A' ' 18' ' ' GLN . 14.7 mt -116.75 152.38 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -92.87 -23.05 18.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 109.741 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.71 70.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.692 HD12 HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -80.68 146.01 31.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 1.6 t-20 -108.72 121.36 44.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.108 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.671 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 5.0 mt -81.35 1.61 31.97 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -89.7 -55.95 3.44 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 4.8 m120 -68.89 -32.66 72.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.925 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -80.21 8.43 7.35 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.689 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 63' ' ' LEU . . . -113.32 -12.98 12.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.084 -1.01 . . . . 0.0 109.065 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -114.22 13.67 17.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 109.762 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.925 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.05 -47.47 98.42 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.075 -1.016 . . . . 0.0 109.9 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.666 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.6 Cg_endo -78.84 -64.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.18 1.92 . . . . 0.0 110.458 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' PRO . 1.4 t -44.46 -26.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' SER . 3.4 tppt? -93.22 -35.76 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HB3' HG22 ' A' ' 75' ' ' VAL . 18.0 m -82.45 2.75 31.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.73 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 52.82 35.29 18.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.416 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -101.76 -31.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 109.084 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 68.33 26.69 6.74 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.725 -0.61 . . . . 0.0 110.081 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.869 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.1 p -79.56 147.77 68.33 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.869 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -86.95 -38.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.296 1.997 . . . . 0.0 108.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.6 p90 -94.14 152.09 19.0 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.832 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.903 ' H ' HG21 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -160.75 163.54 32.22 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.768 ' C ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -51.62 92.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.806 -1.184 . . . . 0.0 108.737 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.562 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 2.4 t -159.33 156.2 25.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 120.891 -1.131 . . . . 0.0 109.693 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' HD22 ' A' ' 61' ' ' LEU . 38.5 Cg_endo -87.7 23.34 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.014 2.476 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 13.5 t70 -149.71 5.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 111.423 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -69.76 -177.86 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.664 -1.272 . . . . 0.0 110.265 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' HG2' ' A' ' 89' ' ' ARG . 38.0 t0 -145.8 125.9 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.957 ' HA ' HD11 ' A' ' 90' ' ' ILE . 1.9 m -89.78 -3.98 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.7 15.86 22.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.277 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.46 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 18.5 mmt180 -116.94 4.93 12.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.031 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -102.51 133.32 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.29 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.483 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.66 ' CG ' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.183 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.813 ' N ' HG23 ' A' ' 46' ' ' THR . 0.5 OUTLIER -53.99 -31.99 52.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 108.694 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . . . -66.46 -53.8 26.6 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' VAL . 1.9 tt0 -62.35 -62.46 1.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.076 -1.25 . . . . 0.0 108.249 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 47' ' ' VAL . 88.9 t -39.17 -44.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.702 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -62.88 -51.37 67.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.998 -1.063 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 m -55.93 -31.12 62.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 110.986 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.512 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mmmm -97.33 -14.71 21.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 111.475 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.723 ' HG3' HD11 ' A' ' 51' ' ' LEU . 4.2 mmt -99.13 -12.77 20.19 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.582 -1.324 . . . . 0.0 109.788 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 20.3 ptmt -77.81 -25.39 0.48 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.671 -0.643 . . . . 0.0 110.71 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 37.2 Cg_endo -83.42 -23.3 3.49 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.739 1.626 . . . . 0.0 108.396 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.3 m -70.79 -5.93 33.93 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.57 0.7 . . . . 0.0 109.232 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.661 HD22 HD11 ' A' ' 58' ' ' ILE . 58.8 mt -66.7 -44.38 81.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.571 -0.706 . . . . 0.0 109.859 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -56.52 -25.08 50.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.849 -1.157 . . . . 0.0 109.749 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CE1' ' OD1' ' A' ' 65' ' ' ASN . 3.9 t80 -89.0 -68.82 0.75 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 109.467 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' A' ' 65' ' ' ASN . 5.4 m -49.43 -24.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 110.937 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.921 ' OE1' HG23 ' A' ' 58' ' ' ILE . 1.7 pt20 -118.38 -44.36 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.871 -1.143 . . . . 0.0 110.311 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -58.0 -43.37 95.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 120.16 -45.52 1.23 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 36.0 Cg_endo -79.01 133.78 11.32 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.014 1.809 . . . . 0.0 110.65 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.35 -167.21 23.91 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.436 ' HG2' ' HE3' ' A' ' 72' ' ' LYS . 35.7 Cg_endo -77.14 175.04 49.89 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.145 -1.606 . . . . 0.0 110.472 -0.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.97 13.23 25.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.47 -48.64 3.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 1.2 pp20? -62.88 -18.88 63.57 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.338 -1.096 . . . . 0.0 109.297 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.75 -56.58 7.62 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.065 -1.022 . . . . 0.0 108.88 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.762 ' HA ' HG22 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -65.38 -33.82 76.87 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.37 -0.831 . . . . 0.0 109.067 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -74.27 -21.23 59.85 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.004 -1.06 . . . . 0.0 108.141 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.18 -52.24 7.96 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 69' ' ' ILE . 13.0 t -60.14 -36.96 71.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.618 ' HA ' HG11 ' A' ' 75' ' ' VAL . 5.9 ttp-105 -64.81 -32.27 73.88 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 12.6 t0 -55.58 -46.08 77.3 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.734 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.6 mp -57.88 -43.81 86.28 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.606 ' CE1' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -48.78 -43.7 38.2 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.634 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -79.59 -26.35 41.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.78 -72.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.825 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -63.29 136.8 57.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.938 ' HB3' HD13 ' A' ' 90' ' ' ILE . 5.0 mpt_? -65.17 -44.08 89.67 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.943 -1.098 . . . . 0.0 108.59 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.865 HE22 HD12 ' A' ' 90' ' ' ILE . 41.1 mm-40 -29.65 -60.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.136 0.494 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.813 HG23 ' N ' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -53.22 -58.18 7.94 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 6' ' ' VAL . 98.3 t -58.13 -78.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.565 0.698 . . . . 0.0 110.889 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 46.9 t -40.66 -61.05 1.0 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.506 -0.746 . . . . 0.0 110.068 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 58.7 m-20 -46.38 -42.33 14.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.99 . . . . 0.0 108.965 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -58.59 -69.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 108.599 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HG3' ' A' ' 10' ' ' MET . 8.6 mp -43.32 -26.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.209 -0.932 . . . . 0.0 110.09 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -71.47 -63.78 1.05 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 108.736 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.11 -54.48 25.95 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 7' ' ' ASP . 42.9 mt -53.53 -66.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 109.108 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB1' ' CA ' ' A' ' 82' ' ' SER . . . -51.23 -20.94 1.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.802 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 1.4 tmm_? -98.69 50.29 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.315 -0.866 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.67 25.53 0.58 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.921 HG23 ' OE1' ' A' ' 18' ' ' GLN . 12.8 mt -114.1 153.9 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.992 -0.711 . . . . 0.0 109.5 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.14 -62.55 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.907 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.95 72.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.978 HD22 ' CD ' ' A' ' 83' ' ' PRO . 1.7 tt -48.22 149.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.85 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -109.06 120.0 41.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.812 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -68.73 -36.64 78.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 65' ' ' ASN . 0.9 OUTLIER -53.44 -56.32 17.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.479 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 48.0 m-80 -64.97 -41.07 95.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.857 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -79.57 5.17 13.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.469 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -113.54 2.64 15.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.298 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.5 t -115.81 0.35 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 110.192 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.62 -49.34 93.24 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.989 -1.07 . . . . 0.0 109.493 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.686 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.4 Cg_endo -78.61 -42.09 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.382 2.055 . . . . 0.0 110.273 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -60.03 -21.55 61.52 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.151 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HE3' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -93.43 -54.69 3.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.9 -0.15 20.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.025 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 50.86 45.83 26.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -93.06 -38.65 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.06 -1.025 . . . . 0.0 109.392 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER 75.08 42.33 0.26 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.767 -0.583 . . . . 0.0 110.836 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.102 HG22 ' HD2' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -79.65 161.84 65.23 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 1.102 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -89.63 -35.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.743 1.629 . . . . 0.0 109.547 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.588 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.3 p90 -98.43 179.11 4.82 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.732 ' H ' HG21 ' A' ' 85' ' ' ILE . 27.2 p -160.86 171.5 18.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -0.975 . . . . 0.0 108.434 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.647 ' O ' ' CG1' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -79.95 83.4 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 123.133 1.444 . . . . 0.0 107.163 178.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.634 ' CA ' ' HB1' ' A' ' 55' ' ' ALA . 1.2 t -151.71 160.84 31.05 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.198 -0.938 . . . . 0.0 109.406 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.978 ' CD ' HD22 ' A' ' 61' ' ' LEU . 37.2 Cg_endo -85.23 26.19 0.66 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.48 2.12 . . . . 0.0 110.188 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' ILE . 40.2 t0 -148.58 -12.44 0.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.781 -1.199 . . . . 0.0 112.407 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -52.46 -178.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.15 -1.594 . . . . 0.0 109.066 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -136.06 119.74 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.508 ' HA ' ' CG1' ' A' ' 90' ' ' ILE . 19.0 m -93.22 -25.15 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.412 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -13.18 55.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.885 . . . . 0.0 109.554 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.88 46.11 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.938 HD13 ' HB3' ' A' ' 44' ' ' ARG . 47.2 mt -83.79 106.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.171 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.465 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.451 0.643 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 1.1 t -82.97 -31.75 27.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.194 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.95 -66.17 2.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -56.03 -62.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.082 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 47' ' ' VAL . 99.2 t -40.66 -31.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.533 -0.73 . . . . 0.0 109.482 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.784 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -73.9 -63.32 1.24 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 108.826 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 8.9 t -49.54 -19.88 0.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -97.34 -29.85 13.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.979 -1.076 . . . . 0.0 110.658 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.889 ' CG ' HD22 ' A' ' 51' ' ' LEU . 1.5 mmm -98.03 -3.17 38.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.747 -1.221 . . . . 0.0 110.739 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.763 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -86.3 -21.71 0.28 Allowed Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 110.338 177.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 35.1 Cg_endo -79.55 -4.38 13.53 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 107.649 -1.712 . . . . 0.0 107.649 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -86.67 0.56 54.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.716 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -57.77 -67.06 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.242 -0.911 . . . . 0.0 109.96 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -39.49 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 110.662 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HD2' HG13 ' A' ' 17' ' ' VAL . 8.3 t80 -81.12 -60.75 2.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.667 -1.271 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 ' N ' ' A' ' 18' ' ' GLN . 25.8 m -64.06 -49.68 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.207 -0.933 . . . . 0.0 111.355 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.647 ' HB3' HG21 ' A' ' 58' ' ' ILE . 1.1 pt20 -91.12 4.97 50.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.906 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -112.07 -56.17 0.46 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.896 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 125.05 -49.44 0.91 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.8 Cg_endo -78.56 115.83 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.221 1.947 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.72 -165.15 29.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 35.1 Cg_endo -79.13 -177.84 22.04 Favored 'Cis proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.125 -1.614 . . . . 0.0 110.48 0.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -86.16 13.56 7.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.218 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.79 3.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 23' ' ' PRO . 1.3 m -60.45 -55.24 35.89 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 29' ' ' ASN . 1.6 p -65.56 -43.12 90.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -62.29 -20.6 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.555 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.76 -56.38 4.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.665 ' HA ' HD22 ' A' ' 34' ' ' LEU . 16.4 t -53.94 -51.29 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.396 . . . . 0.0 108.734 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.626 ' HG3' HG13 ' A' ' 75' ' ' VAL . 10.7 ttt85 -57.79 -30.44 65.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 33.6 t0 -57.87 -46.65 84.55 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.738 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -55.09 -36.69 65.92 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -56.55 -47.17 80.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.965 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.88 -28.7 64.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -81.11 -76.79 0.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.184 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -51.7 139.54 20.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.781 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 73.6 m-20 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.906 0.384 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.819 ' CB ' HG21 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.98 -59.03 2.91 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.87 -1.144 . . . . 0.0 109.769 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.638 HE21 HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -30.51 -37.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.672 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.694 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -66.99 -58.16 5.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.738 ' CG1' HD23 ' A' ' 34' ' ' LEU . 94.7 t -57.04 -58.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 109.952 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 16.9 t -47.02 -49.93 20.25 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.1 m-80 -52.95 -40.56 63.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -63.09 -67.51 0.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.775 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.889 HD22 ' CG ' ' A' ' 10' ' ' MET . 1.9 mt -46.57 -24.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.829 -1.169 . . . . 0.0 108.993 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 16.1 tttm -76.04 -44.56 38.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -63.01 -33.68 87.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.784 HD11 ' HA ' ' A' ' 7' ' ' ASP . 26.4 mt -73.35 -59.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.443 -1.034 . . . . 0.0 109.382 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 82' ' ' SER . . . -57.06 -24.17 51.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.357 -0.839 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.9 36.81 0.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.839 -1.163 . . . . 0.0 109.66 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.88 30.48 2.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.109 -2.397 . . . . 0.0 107.109 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.647 HG21 ' HB3' ' A' ' 18' ' ' GLN . 4.3 mm -110.34 156.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.46 0.648 . . . . 0.0 110.152 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -97.72 -26.79 14.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -146.2 46.69 1.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.74 . . . . 0.0 109.059 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' A' ' 83' ' ' PRO . 2.2 tp -57.0 128.76 38.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -85.49 122.74 30.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.5 mm? -71.56 -33.99 69.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.698 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -53.15 60.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.025 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 39.0 m-80 -64.18 -39.9 94.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.672 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -77.41 -5.04 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 0.0 109.345 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -114.35 15.52 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 14.1 t -129.31 10.63 5.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.672 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -64.46 -51.74 57.9 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 0.0 109.286 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.669 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.1 Cg_endo -77.71 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.315 2.01 . . . . 0.0 109.758 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.75 -23.96 67.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.118 -0.988 . . . . 0.0 108.982 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 68' ' ' SER . 4.4 tptp -85.59 -53.9 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 110.557 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 1.0 OUTLIER -87.57 4.81 42.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.853 -1.155 . . . . 0.0 110.604 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 2.4 m-80 64.16 66.15 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.218 -0.926 . . . . 0.0 111.132 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HG3' ' A' ' 32' ' ' ARG . 2.8 t -118.85 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.72 36.88 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.035 -1.041 . . . . 0.0 110.655 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 79' ' ' TYR . 1.6 p -79.21 141.78 58.27 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.817 -1.177 . . . . 0.0 108.305 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.958 ' CG ' HG23 ' A' ' 90' ' ' ILE . 36.9 Cg_endo -87.09 -35.03 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.422 2.081 . . . . 0.0 108.352 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 17.2 p90 -96.72 173.86 7.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.714 ' H ' HG21 ' A' ' 85' ' ' ILE . 2.8 p -157.31 -171.42 3.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.904 -1.123 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' CD1' ' A' ' 69' ' ' ILE . 1.7 tp -82.9 71.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.576 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -157.45 154.64 25.91 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' HD22 ' A' ' 61' ' ' LEU . 37.1 Cg_endo -83.87 12.43 3.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.755 2.303 . . . . 0.0 110.286 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.64 -7.08 8.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 0.0 110.175 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.714 HG21 ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -55.78 -172.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -0.984 . . . . 0.0 110.334 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -140.8 113.82 8.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 109.391 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HA ' HD11 ' A' ' 90' ' ' ILE . 5.7 m -87.24 -23.99 24.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.197 -0.939 . . . . 0.0 109.668 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 -23.32 55.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.609 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.95 34.87 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.456 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.958 HG23 ' CG ' ' A' ' 78' ' ' PRO . 74.8 mt -90.12 127.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.45 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 13.6 t -99.42 -11.67 20.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.15 -60.48 8.79 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -56.3 -57.91 10.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' CG ' ' A' ' 10' ' ' MET . 46.9 t -48.04 -36.5 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.95 -47.18 63.38 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.008 -1.058 . . . . 0.0 110.497 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.49 -30.46 71.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 0.0 111.404 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -96.27 -17.1 20.98 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.949 -1.094 . . . . 0.0 110.189 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.55 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 18.0 mmt -97.89 -14.98 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.85 -1.157 . . . . 0.0 109.456 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.716 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.91 -28.47 0.9 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 111.184 178.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 36.1 Cg_endo -79.15 -17.86 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.942 ' O ' HG22 ' A' ' 17' ' ' VAL . 19.1 m -74.04 -4.28 34.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 54' ' ' ILE . 33.8 mt -73.35 -36.1 66.08 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.478 -0.764 . . . . 0.0 109.632 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.68 -32.41 71.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.944 -1.098 . . . . 0.0 109.352 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.559 ' HD2' HG13 ' A' ' 17' ' ' VAL . 1.9 t80 -85.26 -66.69 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.146 -0.971 . . . . 0.0 109.056 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.037 HG21 ' CD1' ' A' ' 81' ' ' ILE . 34.3 m -51.54 -20.42 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.284 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.653 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -118.92 -51.4 2.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . -60.31 -43.04 98.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.624 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 121.22 -44.93 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.998 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.0 Cg_endo -77.46 120.61 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.992 1.795 . . . . 0.0 110.844 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 149.7 -168.45 29.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.3 173.29 58.85 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.238 -1.568 . . . . 0.0 110.483 0.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 m -90.84 11.15 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.613 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.99 -47.84 3.19 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -68.21 -20.44 64.84 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.3 -1.118 . . . . 0.0 109.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 m -63.5 -61.97 1.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.02 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . 21.6 p -68.94 -31.86 71.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.37 -0.832 . . . . 0.0 110.05 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 30' ' ' GLY . 1.3 p-10 -71.72 -21.81 61.72 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.674 -1.266 . . . . 0.0 107.941 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -79.91 -50.3 5.62 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.766 ' HA ' HD22 ' A' ' 34' ' ' LEU . 42.3 t -59.83 -45.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.247 . . . . 0.0 108.702 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -58.15 -28.0 64.3 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 9.8 t70 -66.08 -46.89 76.08 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.798 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.5 mp -53.05 -28.9 26.88 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -64.47 -60.38 3.21 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -54.3 -22.73 12.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 108.672 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -80.95 -35.17 32.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.609 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.608 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -71.12 111.44 6.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.229 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 110.303 -179.417 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.974 ' HB3' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 -27.79 16.99 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 7.6 mp0 -59.51 -46.99 87.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.04 -1.037 . . . . 0.0 108.689 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -65.46 -71.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.8 ' N ' HG22 ' A' ' 46' ' ' THR . 24.6 t -44.74 -61.1 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.716 0.77 . . . . 0.0 110.59 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 43.7 t -48.03 -54.7 12.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.693 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 1.9 m-80 -53.83 -29.74 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.086 -1.009 . . . . 0.0 109.135 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 89.9 m -73.32 -70.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.487 -0.758 . . . . 0.0 109.97 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 51' ' ' LEU . 3.3 mt -41.5 -37.18 1.03 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 5.2 tttm -70.59 -45.48 65.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 108.809 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -55.07 -28.78 50.19 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.67 HG22 HD21 ' A' ' 14' ' ' LEU . 19.1 mt -83.92 -70.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -1.099 . . . . 0.0 108.51 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -36.91 -29.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.789 -0.569 . . . . 0.0 110.553 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -85.45 47.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.554 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.34 26.06 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.977 HD12 HD12 ' A' ' 61' ' ' LEU . 28.2 mt -115.1 160.63 14.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 122.027 -0.69 . . . . 0.0 109.514 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.407 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 14.2 m80 -84.06 -61.63 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.935 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.86 63.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 108.945 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 58' ' ' ILE . 1.4 tt -60.56 129.24 40.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 110.032 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.8 121.69 27.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 109.412 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.9 mm? -82.9 4.5 25.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 108.763 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.25 -53.05 4.26 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 39.6 m-80 -67.78 -39.9 84.04 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -75.31 0.47 16.59 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.358 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . -121.04 -2.97 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 109.858 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 4.2 t -112.83 6.0 17.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.722 HD13 ' HB ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -62.25 -50.07 81.47 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.001 -1.062 . . . . 0.0 110.198 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.698 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.6 Cg_endo -76.45 -53.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.301 2.001 . . . . 0.0 110.731 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -27.8 66.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.667 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -80.02 -55.82 4.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.984 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -76.82 -1.73 29.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.371 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 1.4 m-20 69.48 34.44 2.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.842 . . . . 0.0 111.54 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 76' ' ' ASN . 4.7 t -79.96 -129.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.54 -1.35 . . . . 0.0 107.884 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -176.55 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.744 -1.222 . . . . 0.0 109.837 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.766 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -85.49 145.89 43.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.933 ' HG2' HG23 ' A' ' 90' ' ' ILE . 36.4 Cg_endo -86.84 -33.78 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.078 1.852 . . . . 0.0 108.331 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.68 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p90 -99.44 163.86 12.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.111 0.957 . . . . 0.0 110.776 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.851 ' H ' HG21 ' A' ' 85' ' ' ILE . 64.6 p -161.33 165.6 28.82 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.037 ' CD1' HG21 ' A' ' 17' ' ' VAL . 1.4 pp -54.77 94.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 117.587 -1.645 . . . . 0.0 107.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.66 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 29.3 t -172.5 142.78 1.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.045 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.4 8.34 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.723 2.282 . . . . 0.0 110.173 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.74 -16.35 14.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.348 -0.845 . . . . 0.0 110.208 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.851 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -71.49 170.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.908 -1.12 . . . . 0.0 109.933 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -117.31 119.01 33.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.764 ' HA ' HD11 ' A' ' 90' ' ' ILE . 81.7 m -95.67 -17.25 21.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.17 -0.956 . . . . 0.0 109.821 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.98 -4.98 38.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.081 -1.012 . . . . 0.0 109.413 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 34.42 5.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.974 HD13 ' HB3' ' A' ' 44' ' ' ARG . 5.0 mt -86.18 115.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.103 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.489 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 1.7 t -75.97 -25.25 55.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.51 -66.94 2.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -58.01 9.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -1.191 . . . . 0.0 109.034 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.622 ' CG1' HD21 ' A' ' 51' ' ' LEU . 93.9 t -44.81 -27.77 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -76.4 -53.56 7.97 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -58.21 -27.53 63.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -0.823 . . . . 0.0 111.418 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 26.0 mttm -97.51 -28.31 14.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 110.804 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.677 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.66 -2.26 38.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.659 -1.276 . . . . 0.0 110.665 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.797 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -84.07 -21.5 0.29 Allowed Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.24 176.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.797 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 34.9 Cg_endo -79.84 -12.88 13.29 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.2 m -80.57 -2.2 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.87 HD21 HG22 ' A' ' 54' ' ' ILE . 26.4 mt -73.37 -58.61 3.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.488 -0.758 . . . . 0.0 109.799 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -51.82 -18.0 1.14 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.921 -1.112 . . . . 0.0 110.277 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG13 ' A' ' 17' ' ' VAL . 2.2 t80 -90.45 -63.3 1.29 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.875 -1.141 . . . . 0.0 109.814 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 13' ' ' CYS . 35.9 m -54.86 -30.59 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 111.273 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.718 ' CG ' HD13 ' A' ' 58' ' ' ILE . 3.7 pt20 -112.92 -20.15 11.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.751 -1.218 . . . . 0.0 110.627 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -86.64 -46.99 5.0 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.099 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 130.99 -49.74 0.92 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.4 Cg_endo -78.38 144.79 20.69 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.292 1.995 . . . . 0.0 110.957 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.81 -165.27 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 176.14 45.23 Favored 'Cis proline' 0 C--N 1.308 -1.556 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.305 0.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -86.92 155.51 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.301 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.67 83.78 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.495 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -57.59 -40.6 79.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.37 -1.077 . . . . 0.0 109.391 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -48.46 -41.31 29.16 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.918 -1.114 . . . . 0.0 108.822 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 m -77.93 -36.53 49.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 109.778 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 4.9 p-10 -73.62 -7.27 51.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.982 -1.074 . . . . 0.0 108.79 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -98.87 -54.94 1.09 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' HD22 ' A' ' 34' ' ' LEU . 13.9 t -59.94 -37.72 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.095 -1.238 . . . . 0.0 107.755 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.558 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.4 ttm-85 -61.94 -32.64 73.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 10.6 t70 -61.0 -47.06 88.19 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 ' CG1' ' A' ' 47' ' ' VAL . 2.1 mp -55.03 -34.15 63.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.91 -73.89 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.297 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -53.89 -21.86 8.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.348 -0.845 . . . . 0.0 110.879 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 17.6 mm100 -79.56 -35.2 40.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.901 -1.125 . . . . 0.0 109.243 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -63.25 131.09 47.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.795 -179.477 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' CE2' ' A' ' 79' ' ' TYR . 1.7 mpt_? -88.27 -59.57 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.576 ' C ' ' O ' ' A' ' 44' ' ' ARG . 3.3 mp0 -23.08 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.14 0.495 . . . . 0.0 110.299 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.672 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -61.73 -57.88 10.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 108.721 178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.727 ' CG1' HD23 ' A' ' 34' ' ' LEU . 63.4 t -63.26 -72.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.532 0.682 . . . . 0.0 110.323 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -39.39 -55.11 1.81 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 93.7 m-20 -50.87 -46.56 60.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.405 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 33.7 m -54.74 -65.06 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.922 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.677 HD22 ' CB ' ' A' ' 10' ' ' MET . 3.2 mt -44.83 -30.14 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.424 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.999 ' HB2' HD11 ' A' ' 85' ' ' ILE . 55.3 tttt -69.34 -52.08 30.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.99 -43.54 82.83 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.87 HG22 HD21 ' A' ' 14' ' ' LEU . 51.8 mt -61.97 -63.68 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 0.0 108.777 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.768 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -50.19 -22.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -91.73 49.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.099 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.65 23.49 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.718 HD13 ' CG ' ' A' ' 18' ' ' GLN . 14.7 mt -116.75 152.38 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -92.87 -23.05 18.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 109.741 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.71 70.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.692 HD12 HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -80.68 146.01 31.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 1.6 t-20 -108.72 121.36 44.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.108 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.671 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 5.0 mt -81.35 1.61 31.97 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.7 -55.95 3.44 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 16.0 m-80 -68.89 -32.66 72.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.925 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -80.21 8.43 7.35 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.689 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 63' ' ' LEU . . . -113.32 -12.98 12.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.084 -1.01 . . . . 0.0 109.065 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -114.22 13.67 17.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 109.762 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.925 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.05 -47.47 98.42 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.075 -1.016 . . . . 0.0 109.9 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.666 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.6 Cg_endo -78.84 -64.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.18 1.92 . . . . 0.0 110.458 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' PRO . 1.4 t -44.46 -26.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' SER . 3.4 tppt? -93.22 -35.76 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HB3' HG22 ' A' ' 75' ' ' VAL . 18.0 m -82.45 2.75 31.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.73 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.82 35.29 18.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.416 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -101.76 -31.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 109.084 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 68.33 26.69 6.74 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.725 -0.61 . . . . 0.0 110.081 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.869 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.1 p -79.56 147.77 68.33 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.869 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -86.95 -38.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.296 1.997 . . . . 0.0 108.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.6 p90 -94.14 152.09 19.0 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.832 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.903 ' H ' HG21 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -160.75 163.54 32.22 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.768 ' C ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -51.62 92.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.806 -1.184 . . . . 0.0 108.737 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.562 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 2.4 t -159.33 156.2 25.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 120.891 -1.131 . . . . 0.0 109.693 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' HD22 ' A' ' 61' ' ' LEU . 38.5 Cg_endo -87.7 23.34 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.014 2.476 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 13.5 t70 -149.71 5.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 111.423 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -69.76 -177.86 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.664 -1.272 . . . . 0.0 110.265 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' HG2' ' A' ' 89' ' ' ARG . 38.0 t0 -145.8 125.9 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.957 ' HA ' HD11 ' A' ' 90' ' ' ILE . 1.9 m -89.78 -3.98 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.7 15.86 22.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.277 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.46 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 18.5 mmt180 -116.94 4.93 12.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.031 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -102.51 133.32 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.29 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.483 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.768 0.794 . . . . 0.0 109.776 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.66 ' CG ' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -127.13 -18.79 4.49 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.744 -0.597 . . . . 0.0 110.183 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.813 ' N ' HG23 ' A' ' 46' ' ' THR . 0.5 OUTLIER -53.99 -31.99 52.68 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 108.694 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . . . -66.46 -53.8 26.6 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 6' ' ' VAL . 1.9 tt0 -62.35 -62.46 1.75 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.076 -1.25 . . . . 0.0 108.249 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 47' ' ' VAL . 88.9 t -39.17 -44.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.773 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.702 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -62.88 -51.37 67.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.998 -1.063 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 2.3 m -55.93 -31.12 62.63 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 110.986 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.512 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mmmm -97.33 -14.71 21.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 111.475 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.723 ' HG3' HD11 ' A' ' 51' ' ' LEU . 4.2 mmt -99.13 -12.77 20.19 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.582 -1.324 . . . . 0.0 109.788 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 20.3 ptmt -77.81 -25.39 0.48 Allowed Pre-proline 0 C--N 1.294 -1.843 0 O-C-N 121.671 -0.643 . . . . 0.0 110.71 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 37.2 Cg_endo -83.42 -23.3 3.49 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 121.739 1.626 . . . . 0.0 108.396 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.3 m -70.79 -5.93 33.93 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.57 0.7 . . . . 0.0 109.232 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.661 HD22 HD11 ' A' ' 58' ' ' ILE . 58.8 mt -66.7 -44.38 81.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.571 -0.706 . . . . 0.0 109.859 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -56.52 -25.08 50.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.849 -1.157 . . . . 0.0 109.749 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CE1' ' OD1' ' A' ' 65' ' ' ASN . 3.9 t80 -89.0 -68.82 0.75 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 109.467 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.541 ' HA ' ' CB ' ' A' ' 65' ' ' ASN . 5.4 m -49.43 -24.08 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.644 -0.66 . . . . 0.0 110.937 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.921 ' OE1' HG23 ' A' ' 58' ' ' ILE . 1.7 pt20 -118.38 -44.36 2.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.871 -1.143 . . . . 0.0 110.311 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -58.0 -43.37 95.04 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.616 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 120.16 -45.52 1.23 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 36.0 Cg_endo -79.01 133.78 11.32 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 122.014 1.809 . . . . 0.0 110.65 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 134.35 -167.21 23.91 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.436 ' HG2' ' HE3' ' A' ' 72' ' ' LYS . 35.7 Cg_endo -77.14 175.04 49.89 Favored 'Cis proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.145 -1.606 . . . . 0.0 110.472 -0.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.97 13.23 25.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.47 -48.64 3.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 1.2 pp20? -62.88 -18.88 63.57 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.338 -1.096 . . . . 0.0 109.297 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.75 -56.58 7.62 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.065 -1.022 . . . . 0.0 108.88 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.762 ' HA ' HG22 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -65.38 -33.82 76.87 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.37 -0.831 . . . . 0.0 109.067 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -74.27 -21.23 59.85 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.004 -1.06 . . . . 0.0 108.141 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.18 -52.24 7.96 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG21 HG21 ' A' ' 69' ' ' ILE . 13.0 t -60.14 -36.96 71.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.618 ' HA ' HG11 ' A' ' 75' ' ' VAL . 5.9 ttp-105 -64.81 -32.27 73.88 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 12.6 t0 -55.58 -46.08 77.3 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.409 -1.701 . . . . 0.0 106.409 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.734 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.6 mp -57.88 -43.81 86.28 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.606 ' CE1' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -48.78 -43.7 38.2 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.634 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -79.59 -26.35 41.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 110.153 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.78 -72.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.168 -0.958 . . . . 0.0 109.825 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -63.29 136.8 57.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.167 -0.958 . . . . 0.0 109.545 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -118.07 -37.96 3.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.336 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' HD2' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -114.64 176.17 5.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.033 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER -60.41 -50.49 73.38 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.156 -0.965 . . . . 0.0 109.143 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.0 -19.42 5.34 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -87.04 -35.85 18.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -1.17 . . . . 0.0 109.493 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.938 ' HB3' HD13 ' A' ' 90' ' ' ILE . 5.0 mpt_? -65.17 -44.08 89.67 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 120.943 -1.098 . . . . 0.0 108.59 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.865 HE22 HD12 ' A' ' 90' ' ' ILE . 41.1 mm-40 -29.65 -60.16 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.136 0.494 . . . . 0.0 109.974 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.813 HG23 ' N ' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -53.22 -58.18 7.94 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 6' ' ' VAL . 98.3 t -58.13 -78.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.565 0.698 . . . . 0.0 110.889 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 46.9 t -40.66 -61.05 1.0 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.506 -0.746 . . . . 0.0 110.068 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 58.7 m-20 -46.38 -42.33 14.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.99 . . . . 0.0 108.965 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -58.59 -69.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 108.599 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.723 HD11 ' HG3' ' A' ' 10' ' ' MET . 8.6 mp -43.32 -26.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.209 -0.932 . . . . 0.0 110.09 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -71.47 -63.78 1.05 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 108.736 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.11 -54.48 25.95 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 7' ' ' ASP . 42.9 mt -53.53 -66.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.345 -1.091 . . . . 0.0 109.108 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB1' ' CA ' ' A' ' 82' ' ' SER . . . -51.23 -20.94 1.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.281 0.562 . . . . 0.0 109.802 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 1.4 tmm_? -98.69 50.29 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.315 -0.866 . . . . 0.0 109.422 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.67 25.53 0.58 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.921 HG23 ' OE1' ' A' ' 18' ' ' GLN . 12.8 mt -114.1 153.9 15.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.992 -0.711 . . . . 0.0 109.5 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.14 -62.55 1.64 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 109.907 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.95 72.82 1.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.466 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.978 HD22 ' CD ' ' A' ' 83' ' ' PRO . 1.7 tt -48.22 149.27 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.85 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -109.06 120.0 41.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.812 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -68.73 -36.64 78.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.584 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 65' ' ' ASN . 0.9 OUTLIER -53.44 -56.32 17.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.479 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.541 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . 48.0 m-80 -64.97 -41.07 95.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.18 -0.95 . . . . 0.0 108.745 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.857 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -79.57 5.17 13.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.663 -0.648 . . . . 0.0 109.469 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -113.54 2.64 15.42 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.298 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.5 t -115.81 0.35 13.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 110.192 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.857 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.62 -49.34 93.24 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 120.989 -1.07 . . . . 0.0 109.493 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.686 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.4 Cg_endo -78.61 -42.09 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.382 2.055 . . . . 0.0 110.273 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -60.03 -21.55 61.52 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.151 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HE3' ' HG2' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -93.43 -54.69 3.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.333 -0.854 . . . . 0.0 109.798 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.9 -0.15 20.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.025 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 50.86 45.83 26.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 0.0 109.634 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -93.06 -38.65 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.06 -1.025 . . . . 0.0 109.392 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER 75.08 42.33 0.26 Allowed 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.767 -0.583 . . . . 0.0 110.836 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.102 HG22 ' HD2' ' A' ' 78' ' ' PRO . 0.4 OUTLIER -79.65 161.84 65.23 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 1.102 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -89.63 -35.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.743 1.629 . . . . 0.0 109.547 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.588 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.3 p90 -98.43 179.11 4.82 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.732 ' H ' HG21 ' A' ' 85' ' ' ILE . 27.2 p -160.86 171.5 18.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -0.975 . . . . 0.0 108.434 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.647 ' CG1' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -79.95 83.4 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 123.133 1.444 . . . . 0.0 107.163 178.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.634 ' CA ' ' HB1' ' A' ' 55' ' ' ALA . 1.2 t -151.71 160.84 31.05 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.198 -0.938 . . . . 0.0 109.406 -177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.978 ' CD ' HD22 ' A' ' 61' ' ' LEU . 37.2 Cg_endo -85.23 26.19 0.66 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.48 2.12 . . . . 0.0 110.188 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' ILE . 40.2 t0 -148.58 -12.44 0.34 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.781 -1.199 . . . . 0.0 112.407 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -52.46 -178.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.15 -1.594 . . . . 0.0 109.066 -179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -136.06 119.74 17.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.508 ' HA ' ' CG1' ' A' ' 90' ' ' ILE . 19.0 m -93.22 -25.15 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.412 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -13.18 55.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.885 . . . . 0.0 109.554 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.88 46.11 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.867 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.938 HD13 ' HB3' ' A' ' 44' ' ' ARG . 47.2 mt -83.79 106.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.171 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.465 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.802 HD13 ' N ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.204 0.526 . . . . 0.0 109.608 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -158.13 -173.55 4.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.867 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 1.1 t -82.97 -31.75 27.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.194 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.95 -66.17 2.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -56.03 -62.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.082 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 47' ' ' VAL . 99.2 t -40.66 -31.89 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.533 -0.73 . . . . 0.0 109.482 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.784 ' HA ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -73.9 -63.32 1.24 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.404 -0.81 . . . . 0.0 108.826 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 8.9 t -49.54 -19.88 0.65 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -97.34 -29.85 13.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.979 -1.076 . . . . 0.0 110.658 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.889 ' CG ' HD22 ' A' ' 51' ' ' LEU . 1.5 mmm -98.03 -3.17 38.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.747 -1.221 . . . . 0.0 110.739 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.763 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -86.3 -21.71 0.28 Allowed Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.309 -0.869 . . . . 0.0 110.338 177.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 35.1 Cg_endo -79.55 -4.38 13.53 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 107.649 -1.712 . . . . 0.0 107.649 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.5 m -86.67 0.56 54.34 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.716 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -57.77 -67.06 0.37 Allowed 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.242 -0.911 . . . . 0.0 109.96 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -39.49 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.982 -1.074 . . . . 0.0 110.662 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HD2' HG13 ' A' ' 17' ' ' VAL . 8.3 t80 -81.12 -60.75 2.17 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.667 -1.271 . . . . 0.0 109.713 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 ' N ' ' A' ' 18' ' ' GLN . 25.8 m -64.06 -49.68 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.207 -0.933 . . . . 0.0 111.355 -178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.647 ' HB3' HG21 ' A' ' 58' ' ' ILE . 1.1 pt20 -91.12 4.97 50.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 110.906 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -112.07 -56.17 0.46 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.896 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.588 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 125.05 -49.44 0.91 Allowed Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.336 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.8 Cg_endo -78.56 115.83 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.221 1.947 . . . . 0.0 110.522 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.72 -165.15 29.61 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 35.1 Cg_endo -79.13 -177.84 22.04 Favored 'Cis proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.125 -1.614 . . . . 0.0 110.48 0.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.2 m -86.16 13.56 7.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.896 . . . . 0.0 109.218 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.92 -46.79 3.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.279 -1.13 . . . . 0.0 109.772 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 23' ' ' PRO . 1.3 m -60.45 -55.24 35.89 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 29' ' ' ASN . 1.6 p -65.56 -43.12 90.82 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.407 -0.808 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -62.29 -20.6 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.555 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -74.76 -56.38 4.96 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.665 ' HA ' HD22 ' A' ' 34' ' ' LEU . 16.4 t -53.94 -51.29 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.396 . . . . 0.0 108.734 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.626 ' HG3' HG13 ' A' ' 75' ' ' VAL . 10.7 ttt85 -57.79 -30.44 65.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 33.6 t0 -57.87 -46.65 84.55 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.738 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -55.09 -36.69 65.92 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -56.55 -47.17 80.03 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.965 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -70.88 -28.7 64.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' HB3' HD12 ' A' ' 1' ' ' LEU . 16.9 mt-30 -81.11 -76.79 0.23 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.184 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -51.7 139.54 20.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -65.66 1.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.781 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 2.8 m -101.26 -164.36 1.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.514 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 0.2 OUTLIER -72.91 -24.17 60.8 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.67 1.1 39.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 73.6 m-20 -121.55 -29.09 4.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.24 . . . . 0.0 110.041 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.819 ' CB ' HG21 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -73.98 -59.03 2.91 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 120.87 -1.144 . . . . 0.0 109.769 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.638 HE21 HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -30.51 -37.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.862 -0.524 . . . . 0.0 110.672 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.694 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -66.99 -58.16 5.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.738 ' CG1' HD23 ' A' ' 34' ' ' LEU . 94.7 t -57.04 -58.08 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 109.952 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.695 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 16.9 t -47.02 -49.93 20.25 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 1.1 m-80 -52.95 -40.56 63.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -63.09 -67.51 0.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.489 -0.757 . . . . 0.0 109.775 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.889 HD22 ' CG ' ' A' ' 10' ' ' MET . 1.9 mt -46.57 -24.35 0.52 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.829 -1.169 . . . . 0.0 108.993 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 16.1 tttm -76.04 -44.56 38.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 109.517 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.513 ' HA2' ' HG2' ' A' ' 56' ' ' ARG . . . -63.01 -33.68 87.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.784 HD11 ' HA ' ' A' ' 7' ' ' ASP . 26.4 mt -73.35 -59.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.443 -1.034 . . . . 0.0 109.382 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 82' ' ' SER . . . -57.06 -24.17 51.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.357 -0.839 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.557 ' CD ' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -88.9 36.81 0.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.839 -1.163 . . . . 0.0 109.66 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.88 30.48 2.04 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.109 -2.397 . . . . 0.0 107.109 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.647 HG21 ' HB3' ' A' ' 18' ' ' GLN . 4.3 mm -110.34 156.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.46 0.648 . . . . 0.0 110.152 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -97.72 -26.79 14.62 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -146.2 46.69 1.23 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.517 -0.74 . . . . 0.0 109.059 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' HD3' ' A' ' 83' ' ' PRO . 2.2 tp -57.0 128.76 38.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -85.49 122.74 30.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.5 mm? -71.56 -33.99 69.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.698 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -53.15 60.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.025 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' OH ' ' A' ' 16' ' ' TYR . 39.0 m-80 -64.18 -39.9 94.97 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.672 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -77.41 -5.04 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.415 0.626 . . . . 0.0 109.345 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -114.35 15.52 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 14.1 t -129.31 10.63 5.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.299 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.672 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -64.46 -51.74 57.9 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.137 . . . . 0.0 109.286 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.669 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.1 Cg_endo -77.71 -43.77 0.2 Allowed 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.315 2.01 . . . . 0.0 109.758 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.75 -23.96 67.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.118 -0.988 . . . . 0.0 108.982 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 68' ' ' SER . 4.4 tptp -85.59 -53.9 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 110.557 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 1.0 OUTLIER -87.57 4.81 42.2 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.853 -1.155 . . . . 0.0 110.604 -178.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 2.4 m-80 64.16 66.15 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.218 -0.926 . . . . 0.0 111.132 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.626 HG13 ' HG3' ' A' ' 32' ' ' ARG . 2.8 t -118.85 136.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.72 36.88 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.035 -1.041 . . . . 0.0 110.655 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 79' ' ' TYR . 1.6 p -79.21 141.78 58.27 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.817 -1.177 . . . . 0.0 108.305 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.958 ' CG ' HG23 ' A' ' 90' ' ' ILE . 36.9 Cg_endo -87.09 -35.03 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.422 2.081 . . . . 0.0 108.352 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.695 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 17.2 p90 -96.72 173.86 7.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.714 ' H ' HG21 ' A' ' 85' ' ' ILE . 2.8 p -157.31 -171.42 3.6 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.904 -1.123 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.598 HG22 ' CD1' ' A' ' 69' ' ' ILE . 1.7 tp -82.9 71.41 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.576 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -157.45 154.64 25.91 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.393 -178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.544 ' HD3' HD22 ' A' ' 61' ' ' LEU . 37.1 Cg_endo -83.87 12.43 3.0 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.755 2.303 . . . . 0.0 110.286 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.64 -7.08 8.58 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.036 -1.04 . . . . 0.0 110.175 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.714 HG21 ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -55.78 -172.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.126 -0.984 . . . . 0.0 110.334 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -140.8 113.82 8.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 109.391 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.704 ' HA ' HD11 ' A' ' 90' ' ' ILE . 5.7 m -87.24 -23.99 24.54 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.197 -0.939 . . . . 0.0 109.668 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.77 -23.32 55.91 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.143 -0.973 . . . . 0.0 109.609 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.95 34.87 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.456 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.958 HG23 ' CG ' ' A' ' 78' ' ' PRO . 74.8 mt -90.12 127.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.45 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 2' ' ' ASN . 4.0 pp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.797 ' N ' HD12 ' A' ' 1' ' ' LEU . 0.0 OUTLIER -141.15 -165.76 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 13.6 t -99.42 -11.67 20.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.152 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.15 -60.48 8.79 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -56.3 -57.91 10.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 0.0 110.035 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.548 ' O ' ' CG ' ' A' ' 10' ' ' MET . 46.9 t -48.04 -36.5 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.95 -47.18 63.38 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.008 -1.058 . . . . 0.0 110.497 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.49 -30.46 71.23 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 0.0 111.404 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' C ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -96.27 -17.1 20.98 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.949 -1.094 . . . . 0.0 110.189 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.55 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 18.0 mmt -97.89 -14.98 20.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.85 -1.157 . . . . 0.0 109.456 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.716 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.91 -28.47 0.9 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.604 -0.685 . . . . 0.0 111.184 178.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 36.1 Cg_endo -79.15 -17.86 11.57 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.942 ' O ' HG22 ' A' ' 17' ' ' VAL . 19.1 m -74.04 -4.28 34.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 54' ' ' ILE . 33.8 mt -73.35 -36.1 66.08 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.478 -0.764 . . . . 0.0 109.632 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.68 -32.41 71.62 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.944 -1.098 . . . . 0.0 109.352 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.559 ' HD2' HG13 ' A' ' 17' ' ' VAL . 1.9 t80 -85.26 -66.69 0.87 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.146 -0.971 . . . . 0.0 109.056 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.037 HG21 ' CD1' ' A' ' 81' ' ' ILE . 34.3 m -51.54 -20.42 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.577 -0.702 . . . . 0.0 110.284 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.653 ' CB ' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -118.92 -51.4 2.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 18' ' ' GLN . . . -60.31 -43.04 98.99 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.624 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 121.22 -44.93 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.998 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.0 Cg_endo -77.46 120.61 5.31 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.992 1.795 . . . . 0.0 110.844 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 16' ' ' TYR . . . 149.7 -168.45 29.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.3 173.29 58.85 Favored 'Cis proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.238 -1.568 . . . . 0.0 110.483 0.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 m -90.84 11.15 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.613 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.99 -47.84 3.19 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -68.21 -20.44 64.84 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.3 -1.118 . . . . 0.0 109.187 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 m -63.5 -61.97 1.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.338 -0.851 . . . . 0.0 109.02 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 73' ' ' CYS . 21.6 p -68.94 -31.86 71.04 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.37 -0.832 . . . . 0.0 110.05 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 30' ' ' GLY . 1.3 p-10 -71.72 -21.81 61.72 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.674 -1.266 . . . . 0.0 107.941 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -79.91 -50.3 5.62 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.766 ' HA ' HD22 ' A' ' 34' ' ' LEU . 42.3 t -59.83 -45.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.247 . . . . 0.0 108.702 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB2' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -58.15 -28.0 64.3 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 9.8 t70 -66.08 -46.89 76.08 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.798 HD23 ' CG1' ' A' ' 47' ' ' VAL . 1.5 mp -53.05 -28.9 26.88 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -64.47 -60.38 3.21 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -54.3 -22.73 12.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.305 -0.872 . . . . 0.0 108.672 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.535 ' HB3' ' CD2' ' A' ' 1' ' ' LEU . 14.0 mm-40 -80.95 -35.17 32.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.609 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -71.12 111.44 6.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.229 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -151.33 -35.37 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 110.303 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' SER . 45.2 p -78.7 -129.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.924 -1.11 . . . . 0.0 108.242 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -43.63 -28.16 0.37 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.784 -1.197 . . . . 0.0 108.058 178.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.695 ' O ' ' HB1' ' A' ' 38' ' ' ALA . . . 149.4 -27.12 1.22 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER 56.91 18.52 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.974 ' HB3' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -92.75 -27.79 16.99 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 7.6 mp0 -59.51 -46.99 87.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.04 -1.037 . . . . 0.0 108.689 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.8 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -65.46 -71.94 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.8 ' N ' HG22 ' A' ' 46' ' ' THR . 24.6 t -44.74 -61.1 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.716 0.77 . . . . 0.0 110.59 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 43.7 t -48.03 -54.7 12.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.693 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 1.9 m-80 -53.83 -29.74 42.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.086 -1.009 . . . . 0.0 109.135 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 89.9 m -73.32 -70.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.487 -0.758 . . . . 0.0 109.97 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 51' ' ' LEU . 3.3 mt -41.5 -37.18 1.03 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.201 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' ARG . 5.2 tttm -70.59 -45.48 65.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.179 -0.951 . . . . 0.0 108.809 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -55.07 -28.78 50.19 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.67 HG22 HD21 ' A' ' 14' ' ' LEU . 19.1 mt -83.92 -70.74 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -1.099 . . . . 0.0 108.51 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -36.91 -29.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.789 -0.569 . . . . 0.0 110.553 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -85.45 47.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 0.0 109.554 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.34 26.06 0.54 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.977 HD12 HD12 ' A' ' 61' ' ' LEU . 28.2 mt -115.1 160.63 14.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 122.027 -0.69 . . . . 0.0 109.514 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.407 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 14.2 m80 -84.06 -61.63 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.935 . . . . 0.0 109.226 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.86 63.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 108.945 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 58' ' ' ILE . 1.4 tt -60.56 129.24 40.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 110.032 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.8 121.69 27.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 109.412 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 63' ' ' LEU . 3.9 mm? -82.9 4.5 25.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 108.763 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.25 -53.05 4.26 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 39.6 m-80 -67.78 -39.9 84.04 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -75.31 0.47 16.59 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.358 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 63' ' ' LEU . . . -121.04 -2.97 9.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 109.858 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' LYS . 4.2 t -112.83 6.0 17.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 110.335 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.722 HD13 ' HB ' ' A' ' 80' ' ' THR . 0.3 OUTLIER -62.25 -50.07 81.47 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.001 -1.062 . . . . 0.0 110.198 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.698 ' HD3' HD12 ' A' ' 69' ' ' ILE . 35.6 Cg_endo -76.45 -53.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.301 2.001 . . . . 0.0 110.731 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -27.8 66.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.667 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -80.02 -55.82 4.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.984 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -76.82 -1.73 29.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.371 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 73' ' ' CYS . 1.4 m-20 69.48 34.44 2.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.842 . . . . 0.0 111.54 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 76' ' ' ASN . 4.7 t -79.96 -129.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.54 -1.35 . . . . 0.0 107.884 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -176.55 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.744 -1.222 . . . . 0.0 109.837 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.766 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -85.49 145.89 43.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.933 ' HG2' HG23 ' A' ' 90' ' ' ILE . 36.4 Cg_endo -86.84 -33.78 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.078 1.852 . . . . 0.0 108.331 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.68 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p90 -99.44 163.86 12.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 122.111 0.957 . . . . 0.0 110.776 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.851 ' H ' HG21 ' A' ' 85' ' ' ILE . 64.6 p -161.33 165.6 28.82 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.037 ' CD1' HG21 ' A' ' 17' ' ' VAL . 1.4 pp -54.77 94.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 117.587 -1.645 . . . . 0.0 107.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.66 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 29.3 t -172.5 142.78 1.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.045 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -81.4 8.34 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.723 2.282 . . . . 0.0 110.173 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.74 -16.35 14.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.348 -0.845 . . . . 0.0 110.208 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.851 HG21 ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -71.49 170.98 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.908 -1.12 . . . . 0.0 109.933 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -117.31 119.01 33.82 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.764 ' HA ' HD11 ' A' ' 90' ' ' ILE . 81.7 m -95.67 -17.25 21.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.17 -0.956 . . . . 0.0 109.821 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.98 -4.98 38.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.081 -1.012 . . . . 0.0 109.413 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 34.42 5.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.974 HD13 ' HB3' ' A' ' 44' ' ' ARG . 5.0 mt -86.18 115.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.103 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.489 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.381 0.61 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -145.98 -166.58 2.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.098 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 1.7 t -75.97 -25.25 55.68 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.51 -66.94 2.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -58.01 9.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.176 -1.191 . . . . 0.0 109.034 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.622 ' CG1' HD21 ' A' ' 51' ' ' LEU . 93.9 t -44.81 -27.77 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' O ' ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -76.4 -53.56 7.97 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -58.21 -27.53 63.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.384 -0.823 . . . . 0.0 111.418 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 26.0 mttm -97.51 -28.31 14.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 110.804 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.677 ' CB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -98.66 -2.26 38.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.659 -1.276 . . . . 0.0 110.665 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.797 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -84.07 -21.5 0.29 Allowed Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 110.24 176.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.797 ' HD3' ' HG3' ' A' ' 11' ' ' LYS . 34.9 Cg_endo -79.84 -12.88 13.29 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.2 m -80.57 -2.2 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.87 HD21 HG22 ' A' ' 54' ' ' ILE . 26.4 mt -73.37 -58.61 3.19 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.488 -0.758 . . . . 0.0 109.799 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -51.82 -18.0 1.14 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.921 -1.112 . . . . 0.0 110.277 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HD2' HG13 ' A' ' 17' ' ' VAL . 2.2 t80 -90.45 -63.3 1.29 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.875 -1.141 . . . . 0.0 109.814 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 13' ' ' CYS . 35.9 m -54.86 -30.59 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 111.273 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.718 ' CG ' HD13 ' A' ' 58' ' ' ILE . 3.7 pt20 -112.92 -20.15 11.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.751 -1.218 . . . . 0.0 110.627 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 15' ' ' THR . . . -86.64 -46.99 5.0 Favored Glycine 0 N--CA 1.492 2.382 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.099 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.579 ' N ' ' CD ' ' A' ' 21' ' ' PRO . . . 130.99 -49.74 0.92 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.553 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 20' ' ' GLY . 34.4 Cg_endo -78.38 144.79 20.69 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.292 1.995 . . . . 0.0 110.957 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.81 -165.27 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 176.14 45.23 Favored 'Cis proline' 0 C--N 1.308 -1.556 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.305 0.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m -86.92 155.51 20.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.272 -0.893 . . . . 0.0 109.301 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.67 83.78 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -57.59 -40.6 79.42 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.37 -1.077 . . . . 0.0 109.391 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -48.46 -41.31 29.16 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.918 -1.114 . . . . 0.0 108.822 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.0 m -77.93 -36.53 49.25 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.617 -0.677 . . . . 0.0 109.778 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 26' ' ' GLU . 4.9 p-10 -73.62 -7.27 51.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.982 -1.074 . . . . 0.0 108.79 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -98.87 -54.94 1.09 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' HD22 ' A' ' 34' ' ' LEU . 13.9 t -59.94 -37.72 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.095 -1.238 . . . . 0.0 107.755 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.558 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.4 ttm-85 -61.94 -32.64 73.08 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 10.6 t70 -61.0 -47.06 88.19 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.727 HD23 ' CG1' ' A' ' 47' ' ' VAL . 2.1 mp -55.03 -34.15 63.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -60.91 -73.89 0.09 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.297 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -53.89 -21.86 8.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.348 -0.845 . . . . 0.0 110.879 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 17.6 mm100 -79.56 -35.2 40.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.901 -1.125 . . . . 0.0 109.243 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -63.25 131.09 47.23 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.449 -0.782 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -151.62 -39.01 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.014 -1.054 . . . . 0.0 110.795 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.4 m -79.02 -131.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.847 -1.158 . . . . 0.0 109.154 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -45.3 -26.95 0.58 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.74 ' O ' ' HB1' ' A' ' 38' ' ' ALA . . . 152.49 -20.53 0.82 Allowed Glycine 0 C--O 1.208 -1.529 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB2' ' HA ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 58.06 20.52 6.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' CE2' ' A' ' 79' ' ' TYR . 1.7 mpt_? -88.27 -59.57 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.576 ' C ' ' O ' ' A' ' 44' ' ' ARG . 3.3 mp0 -23.08 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.14 0.495 . . . . 0.0 110.299 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.672 HG22 ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -61.73 -57.88 10.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 108.721 178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.727 ' CG1' HD23 ' A' ' 34' ' ' LEU . 63.4 t -63.26 -72.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.532 0.682 . . . . 0.0 110.323 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HB2' ' CG ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -39.39 -55.11 1.81 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 45' ' ' GLN . 93.7 m-20 -50.87 -46.56 60.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.405 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 33.7 m -54.74 -65.06 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.922 . . . . 0.0 109.457 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.677 HD22 ' CB ' ' A' ' 10' ' ' MET . 3.2 mt -44.83 -30.14 0.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.949 -1.094 . . . . 0.0 109.424 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.999 ' HB2' HD11 ' A' ' 85' ' ' ILE . 55.3 tttt -69.34 -52.08 30.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.99 -43.54 82.83 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.87 HG22 HD21 ' A' ' 14' ' ' LEU . 51.8 mt -61.97 -63.68 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 0.0 108.777 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.768 ' HB2' ' C ' ' A' ' 81' ' ' ILE . . . -50.19 -22.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.46 -0.775 . . . . 0.0 109.141 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -91.73 49.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.099 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.65 23.49 0.64 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.718 HD13 ' CG ' ' A' ' 18' ' ' GLN . 14.7 mt -116.75 152.38 18.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -92.87 -23.05 18.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.981 . . . . 0.0 109.741 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.71 70.55 1.41 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.551 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.692 HD12 HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -80.68 146.01 31.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 1.6 t-20 -108.72 121.36 44.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.108 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.671 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 5.0 mt -81.35 1.61 31.97 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -89.7 -55.95 3.44 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' VAL . 16.0 m-80 -68.89 -32.66 72.47 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.925 ' O ' HD11 ' A' ' 69' ' ' ILE . . . -80.21 8.43 7.35 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.689 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 63' ' ' LEU . . . -113.32 -12.98 12.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.084 -1.01 . . . . 0.0 109.065 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 0.2 OUTLIER -114.22 13.67 17.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.404 -0.81 . . . . 0.0 109.762 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.925 HD11 ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -55.05 -47.47 98.42 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.075 -1.016 . . . . 0.0 109.9 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.666 ' HD3' HD12 ' A' ' 69' ' ' ILE . 36.6 Cg_endo -78.84 -64.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.18 1.92 . . . . 0.0 110.458 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 70' ' ' PRO . 1.4 t -44.46 -26.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.407 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' SER . 3.4 tppt? -93.22 -35.76 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.396 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HB3' HG22 ' A' ' 75' ' ' VAL . 18.0 m -82.45 2.75 31.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.73 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.82 35.29 18.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.416 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -101.76 -31.22 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 109.084 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 68.33 26.69 6.74 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.725 -0.61 . . . . 0.0 110.081 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.869 HG22 ' HD2' ' A' ' 78' ' ' PRO . 1.1 p -79.56 147.77 68.33 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.869 ' HD2' HG22 ' A' ' 77' ' ' VAL . 37.4 Cg_endo -86.95 -38.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.296 1.997 . . . . 0.0 108.043 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.689 ' O ' HG13 ' A' ' 77' ' ' VAL . 15.6 p90 -94.14 152.09 19.0 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.832 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.903 ' H ' HG21 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -160.75 163.54 32.22 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.768 ' C ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -51.62 92.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.806 -1.184 . . . . 0.0 108.737 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.562 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 2.4 t -159.33 156.2 25.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 120.891 -1.131 . . . . 0.0 109.693 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' HD22 ' A' ' 61' ' ' LEU . 38.5 Cg_endo -87.7 23.34 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.014 2.476 . . . . 0.0 111.145 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 13.5 t70 -149.71 5.91 0.61 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.585 -1.322 . . . . 0.0 111.423 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -69.76 -177.86 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.664 -1.272 . . . . 0.0 110.265 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' HG2' ' A' ' 89' ' ' ARG . 38.0 t0 -145.8 125.9 13.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.957 ' HA ' HD11 ' A' ' 90' ' ' ILE . 1.9 m -89.78 -3.98 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.7 15.86 22.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.277 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.46 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 18.5 mmt180 -116.94 4.93 12.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.031 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 87' ' ' CYS . 0.5 OUTLIER -102.51 133.32 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.29 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.483 -179.952 . . . . . . . . 0 0 . 1 stop_ save_